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ABSTRACT 
 
Exploring and understanding how the smallest scale features of a cell affect biochemical 
reactions has always been a challenge. Nanoscale fabrication advancements have allowed 
scientists to create small volume reaction containers that resemble the physical scale of 
cell membranes. Engineers seek to use biological design principles to manipulate 
information and import new functionality to such synthetic devices, which in turn, play a 
crucial role in allowing them to explore the effects of physical transport and extreme 
conditions of temperature and pH on reaction systems. Engineered reaction containers 
can be physically and chemically defined to control the flux of molecules of different 
sizes and charge. The design and testing of such a container is described here. It has a 
volume of 19 pL and has defined slits of 10-200 nm. The device successfully contains 
DNA and protein molecules and has been used to conduct and analyze enzyme reactions 
under different substrate concentrations and a continuous cell-free protein synthesis. The 
effect of DNA concentration and slit size on protein yield is also discussed. 
Glucose oxidase and horseradish peroxidase were loaded in the small volume container 
and fed with a solution containing glucose and Amplex Red™ to produce Resorufin. 
Fluorescent microscopy was used to monitor the reaction, which was carried out under 
microfluidic control. Enzyme kinetics were characterized and compared with 
conventional scale results.  
 
Continuous cell free protein synthesis in arrays of nanoporous, picoliter volume 
containers has also been achieved. A multiscale fabrication process allows for the 
monolithic integration of the containers and an addressable microfluidic network. 
Synthesis of enhanced green fluorescent protein (eGFP) in the nanoporous containers 
continues beyond 24 hours and yields more than twice the amount of protein, on a per 
volume basis, than conventional scale batch reactions. These picoliter, nanoporous 
containers provide new ways for quick determination of enzyme kinetics and continuous 
protein synthesis in microfluidic systems. They can be used in a wide variety of 
applications such as drug discovery, clinical diagnostics and high-throughput screening. 
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Chapter 1   
Introduction 
 
 
The cell is the fundamental unit of biological systems. It has the ability of sensing, 
processing information and responding to changes in the environment. The cell operates 
under a wide range of environmental conditions and consists of complex networks of 
interacting molecules, which function within and outside the cell. The complexity of its 
networks allows for self-checking and redundancy which leads to a dynamic robustness 
[1]. The dimensions of the cell are well conserved and its membrane serves as a boundary 
for controlling the transport and detection of chemical signals between cells and their 
surrounding environment. The membrane of a cell is a semi-permeable lipid bilayer, 
which transports proteins and regulates molecular transport through its channels. It is 
changes in protein charge, structure and surface energy combined with membrane pore 
structures that precisely dictate transport and selectivity across the membrane [2-4]. The 
small size of the cell allows for intra and inter-cellular communication through facilitated 
and passive diffusion. It also allows for small fluctuations in molecular concentrations to 
result in significant changes in network interactions. Cells can be highly specialized and 
extremely diverse but still use a common set of building blocks and follow the same 
fundamental principles of thermodynamics and physical sciences [5]. However, 
understanding the organizing principles and the complexity of network interactions has 
been proven to be a difficult task.  Therefore, emulating the properties of biological cells 
becomes a necessary step for better understanding the cell and the functional capabilities 
of its biomolecular systems. 
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There are many challenges and opportunities in mimicking the properties of 
biological cells. Recent advances in nano/micro technology and synthetic biology have 
created the opportunity to match the working level of a cell and gain insight into the 
organizing principles of molecular and network interactions. They have made possible 
integration of nanomaterials into engineering microscale structures that are comparable in 
size with a living cell and mimic its biological properties.  
The objective of this thesis is to develop a cell mimic based picoliter volume 
device that is able to mimic functional aspects of a biological cell, and function as a 
universal platform to study biochemical reactions within a cellular scale system. The 
cellular scale, nanostructured membrane is fabricated in silicon and is used to confine 
DNA, enzymes, proteins, and cell free extract components. Microfluidics are used to 
deliver and remove materials via diffusion-mediated exchange across the membrane 
enabling enzymatic reactions and long-term production of functional proteins. The 
nanostructured membrane facilitates selective material transport and has been modified to 
tune material exchange. Many devices can be implemented in parallel making the 
platform suitable for larger scale production of a single protein or for simultaneous 
functional analyses of multiple proteins.                                 
 The following introduction will provide background and significance of different 
approaches that have been followed in mimicking cell membranes and understanding 
existing biological systems. Chapter 2 provides a description of the approaches taken to 
determine and tune membrane permeability, through control of the physical pore 
structures to control the flux of small molecules and proteins. Chapter 3 describes single 
and coupled enzyme reactions in cell mimic devices. Chapter 4 discusses exploiting the 
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advantages of the small volume cell mimic device to carry cell-free 
transcription/translation and determine the optimal DNA template concentrations 
required for these scale reactions. Chapter 5 extends the results presented in Chapter 4 
and describes the advantages of small volume reaction containers and controlled 
membrane transport for a long-term continuous protein production. Chapter 6 is a 
summary of conclusions and future directions. 
1.1. Synthetic Biology 
 
Synthetic biology is a relatively new notion in life science. It covers a variety of 
disciplines such as molecular biology, systems biology, engineering and physics [6, 7]. 
This emerging field is working toward understanding how biological systems work, by 
modeling and engineering complex reaction networks, carrying out the assembly of 
systems in a synthetic way and defining “minimal” cells capable of sustaining life [6]. 
The term “synthetic biology” was first introduced in 1980 by Barbara Hobom to describe 
bacteria that were genetically engineered by using recombinant DNA technology [8]. The 
term “synthetic biology” was introduced again in 2000 by Eric Kool and other speakers at 
the annual meeting of the American Chemical Society in San Francisco, where the term 
was used to describe synthesis of unnatural organic molecules which can function in 
living systems [6]. The classical meaning of synthetic biology is the use of synthetic 
molecules for obtaining a quantitative understanding of existing biological systems. More 
recently, it has achieved a broader notion by attempting to recreate in unnatural chemical 
systems [9] the properties of living systems such as heredity, self-organization at the 
cellular scale, and directed evolution in order to “redesign life” [6, 10, 11]. Synthetic 
  4 
biologists try to understand “natural” biology by carrying out biological assembly in a 
synthetic way. They also seek to use interchangeable parts from living systems that can 
be tested and used as building units for systems that may or may not have analogues in 
natural living systems [6]. This engineering approach may be applied to all levels of 
biological structures from molecules to cells to organisms [7]. The efforts of synthetic 
biology can be better categorized as a “top-down” or “bottom up” approach. The “top-
down” approach uses entire genomes, as blueprints to better understand gene function in 
a cell. A key focus is on constructing minimal cells by the reduction of genomes in order 
to determine the minimal number of genes capable of sustaining life [12-15]. Rewriting a 
complete genome can enable a better understanding of gene function by observing 
differences in observed and predicted behavior of cells. A few groups are working on 
creating bacteria with chromosomes that have been completely synthesized from 
synthetic oligos [16]. This can be accomplished stepwise [17] or by inactivating and 
removing the entire genome of the bacteria and replacing it  with a whole in vitro 
synthesized genome[16].  Another goal of the “top-down” approach is to test theories 
about the minimum number of genes required for bacterial survival and replication [18-
20]. It can also develop minimal living systems which can then serve as units that can be 
augmented for specific purposes [21]. The “top down” approach has been based on the 
stipulation that closely related genomes have genes that are required for those species but 
are not required for basic life. Therefore, to test theories of the minimum number of 
genes required for bacterial replication, a systematic removal of “indispensable” genes by 
mutating them one gene at a time has been applied to the genomes of Escherichia coli 
and Mycoplasma bacteria [16, 17, 22]. Another goal of the “top-down” approach is to 
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create bacteria with globally mutated genomes rather than truncated ones, which can 
make possible the extension of the genetic code with unnatural amino acids[23] and 
prevent functional exchanges of genetic material with natural species, therefore 
decreasing the chance of environmental contamination [16]. However, there are many 
challenges to this approach such as the presence of false “essential” and “dispensable” 
genes and the fact that more than a third of the discovered essential genes have unknown 
functions [15]. 
On the other hand, the “bottom-up” approach follows the strategy of constructing 
engineered genetic circuits or simplified systems to better understand molecular and 
cellular regulatory processes and to obtain simple systems with desired capabilities [5, 7, 
24-26]. The genomic-based information and the control mechanisms that are being 
obtained from this approach are making possible redirection of living systems by 
engineering specific genetic circuits such as toggle switches, repressilators and logic 
switches [27-30]. These engineered gene circuits can be used to test theoretical models, 
and advance our understanding of biological complex systems[31]. The engineering 
community has taken “bottom-up” synthetic biology a step further. They seek to extract 
interchangeable parts from living systems, which could be tested, validated and 
reassembled to create devices with optimized metabolic pathways for the production of 
desired reagents [6, 32-34]. A great variety of synthetic networks have been applied in 
cells by rearranging regulatory components into genetic oscillators [29], artificial 
population control based on quorum sensing [35], a bistable circuit [30], and a sender-
receiver system [36]. Noireaux et al constructed cell-free gene circuits consisting of 
engineered repression cascades and transcriptional activation. In these cascades, the 
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protein products of the first stage were used as input activators or inhibitors of the next 
stage. Using this approach, they constructed one-, two-, and three-stage gene expression 
cascades, which were used to study parameter ranges and basic principles of genetic 
circuit assembly [31, 37]. Elowitz and Lieber designed an artificial oscillator module 
from three regulating genes [29]. This “repressilator” was wired into the circuits of E. 
coli and induced periodic on-off switching of genes. The periodic on-off switching was 
visible by coupling the module to the synthesis of green fluorescent protein (GFP) [27]. 
Other gene modules that have been used in a “bottom up” fashion for controlling and 
understanding bacterial behavior are toggle switches. These switches can be flipped into 
an on or off state by an environmental signal or quorum sensing autoinducer [27]. A 
different approach was taken by Weiss and co-workers toward artificial pattern formation 
[35]. They generated an artificial gene network that responded to different concentrations 
of diffusible quorum sensing autoinducers. The artificial gene network was implemented 
in E. coli and the bacteria were grown in a Petri dish surrounded by different localized 
sources of autoinducers. The diffusion of the autoinducers from the sources turned on 
expression in bacteria and led to spatial patterning of the biofilm[35]. Other groups have 
also studied spatio-temporal effects induced by varying chemical “sources” via reaction 
diffusion in the form of genetic oscillators or pulse generators. Reaction diffusion 
systems have also been used to produce nano and microscale patterns [38].   
In principle, systems with integrated elements that act as signal transducers, 
molecular sensors, and genetic regulators, can be used as simple models of biological 
control circuits. The reduced number of components in these systems allows for an 
accurate computational prediction of their behavior, which can be used to improve their 
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design[31]. However, the “top-down” and “bottom-up” approaches still rely on the use of 
biomolecules and an existing cellular environment to start and validate cellular function 
[5]. Modeling and analysis of these systems are difficult because of the many unknown 
parameters in the cell environment. Therefore, in vitro reconstruction of genetic circuits 
with known components in a cell-like environment is a possible option to overcome these 
limitations [31].  Designing biological devices that mimic a biological cell and allow for 
formation of complex systems from their basic functional parts, sense abnormal 
conditions and dose response in real-time, and perform metabolic and biosynthetic 
functions[7], can lead to a system with true “bottom-up” cell-like characteristics.  
The advancements in techniques and approaches described above have created 
significant opportunities to modify single living cells and multicellular species [39]. 
However, there are also major limitations associated with these approaches such as high 
cost, low efficiency of scale, safety and ethical issues. Furthermore, combining non-
biological with cellular techniques is often difficult, the resulting products of the genetic 
manipulations could be toxic to the cells and there is also the need for specialized nutrient 
media to grow certain genetically modified cells. Therefore, an alternative approach is to 
build cell-like devices that are engineered specifically to encapsulate components for 
certain applications [39]. These cell-like devices can function as containers for artificial 
cellular systems and must be able to exchange nutrients, ions, regulatory molecules and 
remove waste products between the device and the environment. Internal organization of 
compartments could be used for localized production and micron-scale assembly line 
formation [31].  
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1.2. Mimicking cells  
 
Mimicking cells has been the focus of researchers for many decades. Several 
efforts have been employed for the development of platforms that mimic and apply 
functional aspects of the cell and its ability to contain pico/nanoliter volumes of liquid on 
reaction effectiveness [39-44]. These small volume containers have a variety of different 
nomenclature such as cell mimics, minimal cells, cell-like entities, nanoreactors, artificial 
cells and in vitro compartmentalization devices. A common feature of these platforms is 
their ability to contain small volumes of liquid and reduce the number of molecules 
needed to carry out a function. Due to their small volume, they can also establish 
favorable local conditions for protein functions and eliminate the need for mixing [5]. 
Therefore, the small volume containers are ideal for understanding self-organization at a 
cellular scale and studying single molecule reactions. They are also useful as platforms 
for understanding molecular reaction systems and questions involving the origin of life 
[4, 5, 45-49]. A more practical use for biomimetic devices is for high-throughput 
screening [50, 51] or synthesis of products that are toxic to natural cells [52-54]. 
Furthermore, the containers can be used for drug delivery, chemical sensing, signal 
amplification, detection of nonsense or frame-shift mutations in marker genes [55-57], 
protein production [58-65] including pharmaceutical proteins [66, 67] and patient-
specific vaccine candidates [66, 68], synthesis of drug transporters[69], toxin detection 
[70] and preparation of nanomaterials [71-73]. Finally, cell-mimic devices can be used to 
study evolutionary aspects of the cell and also study stochastic effects on the performance 
of artificial gene networks [31]. However, the parallel pursuits for creating functional 
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mimics of cells have the containing membrane as a distinguishing feature from each 
other. 
1.3. Vesicle systems 
There are many different materials that have been used to mimic the membrane of 
a cell. Self-assembled vesicles prepared from amphiphilic molecules are the most 
common approach for the formation of synthetic membranes. These structures can be 
formed from synthetic molecules such as block copolymers [72, 74], or from lipids. 
Block copolymers consist of at least two parts of different solubility, which gives them 
the ability to self-assemble into a variety of structures including vesicles mimicking a cell 
membrane [5, 75, 76]. Depending on the type of polymer, molecular weight and block 
ratio, different vesicles with a wide range of physical and chemical properties can be 
created and used for reagent delivery, chemical sensing and reaction containment [75-
77]. Enzyme activity can be conserved inside polymersomes, which makes these vesicles 
applicable for sensing and stimulus response. They have also been used for incorporation 
of natural energy-transducing membrane proteins and demonstrated the potential use of 
these systems for energy conversion processes of natural systems [5].  
Membranous vesicles consisting of lipid bilayers have been used in laboratories 
for more than 40 years. Lipid bilayer vesicle preparation is a mature field that has been 
used for many years by the pharmaceutical industry in cosmetic preparations and as drug 
delivery agents [39]. These self-assembling structures formed from lipids are called 
liposomes. They were first prepared in the 1965 by Bangham and his team and can be 
prepared by different techniques [39, 78, 79]. The first liposomes were called multi 
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lamellar vesicles (MLVs) because they consisted of hundreds of concentric lipid bilayers 
[39]. Since the multilamellar characteristic can be a limitation, small unilamellar vesicles 
(SUVs) were prepared by sonicating MLVs. The liposomes consist of natural 
components and they have distinct advantages over other vesicles. They can be created in 
cell comparable scales and can allow for pore-forming proteins to be incorporated. 
Liposomes that allow small molecules to pass through but retain macromolecules can 
also be prepared by choosing short-chain lipids [39]. Although many neutral small 
molecules can diffuse through the walls of the lipid bilayer, their permeation properties 
can be regulated based on the chain length and composition of their lipids. Liposomes 
can contain chemical reactions and have been useful in understanding diffusion, 
permeability and other physical properties of the cell membrane. They can also protect 
enzymes from degradation and help in better understanding the biological properties of a 
cell membrane [5]. Liposomes have been used to study many gene-based reaction 
systems such as protein production involving a gene sequence, mainly green fluorescent 
protein (gfp) gene, with a promoter and cell-free extract [80-85]. Complex genetic 
reactions have also been achieved in liposomes. A two-stage genetic network stage was 
demonstrated by Ishikawa et al, where the protein produced in the first stage is required 
for activating protein synthesis in the second [86]. Noireaux et al has demonstrated other 
multi-stage reaction systems [44]. Many groups have also shown that enzymes entrapped 
inside of a liposome can be used for catalyzing reactions [87, 88], for metabolizing toxic 
reagents [89], or for diagnostic applications [90].  
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1.4. Water in oil emulsion systems 
 
Water in oil (w/o) emulsions have also been used to create small volume 
biomimetic devices. Femtoliter volume containers can be prepared by stirring a mixture 
of oil, aqueous solution and appropriate surfactants [42, 91-93]. Strong shaking or 
ultrasonication can be used to make even smaller size droplets [94]. Microfluidics 
technology has also been used to generate droplets of defined composition and size. This 
approach allows for easy manipulation where mixing and compartmentalization of 
reagents can be obtained by the merging of microfluidic flow streams[5, 95]. Since w/o 
techniques can create a large number of small volume reaction containers, they have been 
used for a variety of applications such as quantifying genetic variation within individual 
alleles [96], amplifying and characterizing complete genomic libraries [97, 98], linking 
genotypes with phenotypes and high-throughput screening and selection [99, 100]. In 
these approaches, the genes or whole genomes together with specific polymerases and the 
reagents for transcription/translation are contained inside the aqueous compartment. 
Direct assessments of specific protein functions can be made. On the other hand, the 
amount of reagent available and inhibitory byproduct formation, limit the reaction inside 
the vessel since reagent exchange within the oil phase is unlikely. Researchers are trying 
to enhance reagent transport in and out of the w/o emulsion reaction vessel by allowing 
individual vessels to physically contact or fuse with each other [91, 101, 102].  
Self-assembly based simply on molecular recognition, may not be enough to 
produce all the desired structures of different spatial and temporal order. Therefore, 
developing artificial systems, which can be used for the assembly of synthetic structures, 
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are necessary [31]. Engineered synthetic spatio-temporal gene networks have been 
developed by Isalan et al to emulate Drosophila embryonic pattern formation [103]. They 
modeled embryonic cells using a spatially extended expression network, which was 
formed by using “gene”-coated paramagnetic beads that were held in place by magnets in 
a reaction chamber. Gradients of activators that were generated from different local 
sources in the network were able to activate repressor protein production from bead-
immobilized genes. Diffusion of the newly produced repressor protein, led to a spatial 
modulation of gene expression patterns resembling gap formation in the Drosophila 
embryo [103]. This chip-based expression system is of interest for studying the spatio-
temporal effects and synthetic developmental systems in vitro  [31].   
Major advantages of these cell mimic devices are their ability to self-assemble 
and to be produced with simple techniques. However, the small volume reaction 
containers described above, do not have long-term stability. They are relatively fragile 
and sensitive to temperature, stress, and pH. They are also easily damaged by low 
mechanical stress, which makes them unable to survive most micro- and nanoscale 
fabrications. The fixed dimensions of their pores can also limit their applicability. 
Therefore, a more robust reaction platform with a defined volume, pore sizes and design 
could be advantageous.  
1.5. Nanotechnology approach in cell mimicking 
 
Advancements in nanotechnology and microfabrication techniques have allowed 
researchers to work at the atomic and molecular levels [104]. They can match the 
working scale of a living cell and provide platforms and cell mimic devices that can be 
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used for a bottom-up construction of nanosystems with cell-like characteristics. 
Nanotechnology has provided the tools and technology platforms to better understand 
biological systems by having the ability to arrange molecules into objects of several 
length scales and also to disassemble objects into molecules. This is achieved by 
rearranging matter using ‘weak’ molecular interactions such as hydrogen bonds, van der 
Waal forces, various surface forces and electrostatic dipoles[104]. Nanotechnology was 
initially classified into wet and dry nanotechnology. Wet nanotechnology includes living 
biosystems whereas dry nanotechnology is searching for approaches to engineer man-
made structures at the nanoscale level and to integrate these structures into more complex 
systems [104]. Although nanotechnological approaches may differ from the evolving 
systems found in nature, many concepts such as surface interactions of various shapes, 
self-assembly and self-repair can be used as inspiration for nanotechnology [104]. 
Model biological systems models and biotechnology combined with the tools and 
investigation platforms that are provided by nanotechnology have led to a new branch of 
nanotechnology called nanobiotechnology. It applies nanoscale techniques and principles 
to better understand biological systems. It also uses biological materials and principles to 
create devices that can be integrated from the nanoscale level [104]. The approach used 
by nanobiotechnology has uncovered many fundamental biological processes and key 
advancements have been made in understanding biological processes such as self-
assembly and self-organization [105, 106], self-repairing, nanoscale surgery, eco-
toxicology [107], pollution by nanoparticles [108], protein dynamics, synthesis and 
targeted delivery of drugs [109], enzyme reactions and cell signaling [104, 110, 111]. 
Other contributions include development of color changing nanoscale systems for 
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displaying protein unfolding events[112], using rectified Brownian motion to explain 
kinesin motion along microtubules and chemomechanical energy conversions of 
intracellular processes [113]. Nanobiotechnology is also playing an important role in 
emerging areas such as the study of tissue regeneration mechanisms, realistic molecular 
modeling of soft matter, and understanding energy supply and conversion in the cell 
[104]. 
Nanobiotechnology has been combined with Micro-Electro-Mechanical Systems 
(MEMS), which are miniature devices that integrate electrical and mechanical 
components on a silicon substrate [114]. These devices vary in size between nanometer to 
millimeter level. Applications of MEMS in biology and chemistry have led to the 
creation of new platforms called BioMEMS (biological or biomedical Micro-Electro-
Mechanical Systems). BioMEMS have been taken a step further to create Lab-on-a-Chip, 
which is a device or a system of devices that are used to perform a combination of 
biological and clinical assay analysis on a single mimic device [114]. Mimicking the 
principles and concepts of biology have led to the controlled self-assembly of arrays of 
nanoparticles, macromolecular crystals and devices for use in nanoelectronics. Structure 
replication [12], mimicking photosynthesis [115], neuromorphic engineering [116] and 
the development of bioreceptors and biomarkers, are more examples of using biological 
paradigms to create semibiological hybrids and artificial nanoscale devices [104]. 
Different fabrication techniques such as drilling, etching, molding or embossing have 
been used to create new devices of various sizes, which are based on concepts and 
principles from natural systems. They have been synthesized from a wide variety of 
materials such as oxide films being etched by ion beam [117, 118], track etching 
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nanopores in polymer films [119], using soft lithography [120] and from carbon 
nanotubes [121, 122]. These devices can enhance our ability to interface and understand 
basic questions regarding biological functions such as mimicking photosynthesis [123], 
creating large molecular structures [106], neuromorphic engineering [116], and 
developing bioreceptors and biomarkers [104]. These small volume devices can relieve 
the need for structures or devices for mixing, decrease the number of molecules required 
for carrying out a reaction and decrease analysis time and rapid heat exchange when 
compared to traditional analytical systems [124]. They can also be modified to control the 
flux of different size molecules and can facilitate kinetic studies [125-128]. For example, 
these small volume devices have been developed and used for single molecule 
enzymology [129, 130], cell-free protein synthesis [63, 131-134], high-throughput 
screening [71, 131], and novel functional assays [70, 135].   BioMEMS devices are 
fabricated using mainly two categories of materials. The two categories are (1) silicon 
and glass and (2) polymers and plastic materials (Figure1.1). 
 
1.6. Silicon and glass micromachining methods 
 
Silicon and glass micromachining methods of fabrication are the most popular 
approach for cell mimic device formation, especially since they use a wide variety of 
technologies for bulk micromachining, lithography and surface machining. Silicon 
methods of fabrication start with single crystalline silicon wafers, which undergo 
different deposition techniques for a number of layers such as silicon dioxide, 
polysilicon, metal, and silicon nitride. Wet or dry etching techniques can also be 
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Figure 1-1:  Materials, fabrication techniques and applications for BioMEMS devices. 
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used to make the device and/or the microchannel. The pores in the membrane of the 
device are usually made by making holes through the synthetic material. Common 
techniques used to achieve this are track etching, anodic oxidation, and ion beam etching 
[114, 136].  
Glass methods of fabrication are also as popular as silicon, mostly due to 
favorable properties of glass such as high chemical resistance, high mechanical strength, 
wide optical transmission range and high electrical insulation. Glass can be photo 
patterned using dopant photosensitive materials or it can be etched using buffered 
hydrofluoric acid with metal masking layers and photoresist [114, 137]. Glass channels 
with straight walls can be also obtained by using deep RIE [138]. Although 
micromachining techniques are widely used, silicon and glass based devices have some 
drawbacks such as their surface characteristics may not be well suited for all biological 
applications.  Other drawbacks include the need for expensive equipment and facilities, 
they are also labor intensive, require highly specialized skills and can be costly to 
manufacture. Therefore, a less expensive, less specialized and faster method for device 
fabrication is necessary to promote a widespread use of microfluidic devices in biology 
[139]. 
1.7. Polymers and plastic materials  
 
In the past few years, more research groups have started to use plastic materials 
and polymers for fabricating BioMEMS. The main reasons for using these materials are 
their low cost and multi-functionalities [140, 141]. There are a wide variety of plastic 
materials and polymers with different physical, chemical and biological properties, which 
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makes them adaptable for different applications. It is also easier to interface biological 
tissues to the polymer materials. Their bio-degradability, lack of immuno-inflammatory 
initiation and lower toxicity allow for in vitro applications of devices made from these 
materials. The methods used to fabricate these microdevices include soft lithography, hot 
embossing, mold injection, micromilling and laser ablation [142]. Soft lithography is the 
most popular alternative approach to silicon and glass micromachining. It was first 
developed in 1974 at Bell Labs when researchers developed a new technique to use a 
lithographic master for molding soft materials [139]. Soft lithography has been used to 
pattern surfaces and fabricate microchannels via stamping, molding and embossing. 
Typically, soft lithography refers to the molding of polymers and different plastic 
materials, using photoresist masters. Polymers are the most common material used for 
soft lithography and BioMEMS fabrication. They have unique properties such as 
biological and chemical compatibility, easy fabrication, good thermal properties, optical 
transparency and high electrical insulation[114]. Polymer enzymes are usually 
synthesized using soft lithography techniques. Commonly used polymers for soft 
lithography are PDMS, PMMA and SU-8. PDMS is a hydrophobic polymer, which is 
prepared by mixing a curing agent with a pre-polymer [143]. PDMS can be cured by heat 
or UV light and based on its properties it is considered an ideal material for soft 
lithography [144]. It is optically transparent, durable and self-seals ability to a wide range 
of surfaces. It also has a modifiable interfacial energy, which makes its surface dynamic 
and overall a good material for building micro-fluidic devices and channels [114]. Porous 
membrane devices can be formed by micromolding the PDMS. In this procedure, 
degassed PDMS is poured over a patterned substrate and left to cure for 1-2 hours. The 
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impression of the pattern of the substrate is then left on the PDMS after it is cured around 
the etched substrate. Therefore, the design features of a PDMS device are only limited by 
the master from which it is molded. Devices that are formed this way have been shown to 
have pores as small as 30 nm [145]. PDMS is biocompatible and devices prepared from 
this material have been used in a variety of applications such as culturing bacteria and 
mammalian cells, protein production and enzyme kinetics. Micromachining and 
photolithography have been used to fabricate complex masters to mold PDMS 
microstructures, including ones with multidimensional layers [146].  
Soft lithography has also been used to describe hot embossing techniques, which 
are used to transfer a pattern from a metal master or a micromachined quartz to a flexible 
plastic sheet. The plastic sheet becomes imprinted to the master by applying heat and 
high pressure. Many plastic printed surfaces can be formed from one micromachined 
master and then bonded to plastic covers to form microchannels [147]. The most 
commonly used plastic for hot embossing is polymethylmethacrylate (PMMA), which is 
the least hydrophobic of most common plastics. It is also known as Plexiglass, Acrylic, 
Lucite etc, and was originally used as resist material for Lithography, Electroplating and 
Molding techniques (LIGA techniques) [137]. It is thermoplastic and noncrystalline in 
nature with a 92% optical transparency [148]. It can be reused many times by reheating 
and reshaping it into different forms. It also possesses many other features such as high 
chemical resistance, low frictional coefficient and good electrical insulation. The surface 
of PMMA can be modified by oxygen plasma exposure or X-ray irradiation in order to 
modify its surface properties for biomedical applications [114, 137]. Hot embossing of 
PMMA enables construction of low cost devices and is appropriate for finalized device 
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design. However, it can be time consuming and expensive if new features need to be 
added to the platform since a new micromachined master is required. SU-8 is another 
polymer that is commonly used as a material for BioMEMS applications. It is in a liquid 
form consisting of a solvent, an epoxy resin and a photoacid generator. Generally it is 
used for making simple and inexpensive thick photoresists for high aspect ratio 
structures. It has good temperature and chemical resistance and can be patterned to create 
nearly vertical sidewalls [114]. Other approaches for constructing microfluidic devices 
consist of micromolding or using photodefinable polymers. Micromolding is inexpensive 
and takes advantage of thermoplastic polymer materials, which are heated past their glass 
transition temperature and are molded into a lower temperature master. Photodefinable 
polymers are used to create devices that are called microfluidic tectonics. These devices 
are relatively cheap and are constructed using lithography, photopolymerizable materials 
and laminar flow.  
Synthetic membranes have many advantages over membranes made from 
biological components. They are more robust and can withstand a wide range of 
environmental conditions such as pHs, temperatures and pressures, which makes them 
easier to integrate with micro-scale systems. It is also feasible to develop synthetic 
devices with specific material composition, dimensions and design, which make them 
very flexible for a wide range of applications. The challenge for synthetic cell membranes 
remains the efficiencies and multifunctionality that is present in a biological membrane. 
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1.8. Microfluidic technologies 
 
No matter what material is used to make cell mimic devices, these devices still 
cannot perform high-throughput experiments at a cellular scale or under a variety of 
specific environmental conditions. Microfluidic technologies can overcome these 
limitations by taking advantage of the same microfabrication techniques used to pattern 
cell mimic devices on silicon, glass or PDMS wafers[149]. The low cost of production 
and small-scale give microfluidics the ability to perform procedures such as biological 
and chemical sensing, high-throughput screening and genetic analysis[149]. The 
laborious and time-consuming efforts to save chemical compounds and conduct high-
throughput screening applications have led to miniaturization of existing technologies 
and the introduction of nanoliter dispensing systems and high-density plate formats[150]. 
Microfluidic chips are small platforms that consist of channel systems connected to liquid 
reservoirs via tubing systems. The fabrication of microfluidic chips usually requires 
cleanroom facilities and consists of a variety of materials and fabrication techniques. 
However, the majority of microfluidic devices are simple planar microchips fabricated on 
silicon, glass or polymers via photolithography [150-152]. Due to short distances and 
high surface to volume ratio, transport times of mass and heat are shortened in 
microfluidic channels and multi-step reactions can be easily performed. Most 
microfluidic devices are miniaturized versions of macroscale systems and they do not 
take full advantage of the properties unique to the microscale. However, the number of 
microfluidic devices that operate under continuous flow and take advantage of the effect 
of laminar flow and diffusion in microscale is growing. Operating under continuous flow 
allows for on-line analysis, combination of multiple reaction steps, and shortened 
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reaction times, resulting in faster optimization of reaction parameters [150].  The small 
size of microfluidics also allows for the incorporation of multiple aspects of modern 
biology or chemistry labs onto a single microfluidic device. These integrated microfluidic 
devices are called Lab-on-a-Chip (LOC) or micro-Total Analysis Systems (µ-TAS) and 
they have been used for different techniques such as Polymerase Chain Reaction (PCR), 
Fluorescence Activated Cell sorting (FACS) and cell culturing [150]. Many Lab-on-a-
Chip devices can include multiple analysis steps such as cell sorting and concentration, 
growth and detection followed by cell lysing and PCR. Recent advances in fluorescent 
imaging techniques combined with microfluidics have created opportunities to study 
signaling networks and perform live cell experiments [149]. Fluorescent imaging can be 
performed within microfluidic devices by taking advantage of the small-scale of 
microfluidics, which allows for subcellular manipulations of molecules and highly 
specific control of the cellular microenvironment [153]. Furthermore, visualization of 
molecular movement within whole cells conducted in high-throughput microfluidics, 
allows for large-scale determination of dynamic properties such as spatial and temporal 
characterization, which have recently been used to develop mathematical models of 
biological systems [153, 154].  Burns et al fabricated a microfluidic platform with 
nanoliter DNA analysis devices with integrated heaters, temperature sensors and 
fluorescent detectors. The platform was used to perform sample loading, mixing, PCR, 
electrophoresis and detection simultaneously in a single chip [155]. Mathies group also 
developed 16, 48 and 96 microchannel electrophoresis microchips, which were used for 
genotyping and DNA sequencing [156].  
  23 
Here, we have developed a cell mimic based picoliter volume device in a 
microfluidic platform that is able to mimic functional aspects of a biological cell. It 
operates under continuous flow and takes advantage of the effect of laminar flow and 
diffusion in microscale. Materials are delivered and removed via diffusion-mediated 
exchange across the membrane enabling enzymatic reactions and long-term protein 
production. The nanostructured membrane has been modified to control and facilitate 
material exchange and transport. Many devices have been implemented in parallel 
making the platform suitable for larger scale production of a single protein or for 
simultaneous functional analyses of multiple enzymes and proteins. 
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Chapter 2  
Determine and tune membrane permeability, through 
control of membrane pore properties to control the flux 
of small molecules and proteins 
2.1. Introduction 
 
Understanding the physical phenomena that influence microscale interactions is a 
key factor when working with microfluidics and cell mimic devices. Therefore, new 
microscale devices must be made to take advantage of forces that are dominant at the 
microscale. Surface area to volume ratio, laminar flow and diffusion are three main 
physical characteristics that influence the performance of microfluidic devices[139]. 
Laminar flow is a fluid flow regime in which the velocity of a particle in a stream is not a 
random function of time [139].  Due to the short length of a microfluidic channel, the 
flow is generally laminar, which allows for precise calculation of mass transport as a 
function of time, using parameters such as fluid properties and channel geometry. 
Consequences of laminar flow in microfluidic channels include the ability to flow two or 
more streams in contact with each other without mixing, which allows for creating well-
formed packets of fluid[139]. Since laminar flow allows for different reagents to perfuse 
barrier-free next to each other, localized treatment of cells can be easily achieved in 
microfluidic platforms. Chemical gradients with sub-cellular resolution can also be 
constructed by combining laminar flow with a controlled mixing by diffusion[149].  
Diffusion is another important factor to be considered when working with 
microfluidic devices. It is defined as the process by which, based on the Brownian 
motion, a concentrated group of particles in a given volume will spread evenly over time 
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so that throughout the volume there is a constant average concentration.   Diffusion is 
measured in one dimension by the equation d2=2Dt, where d is the distance that the 
particle moves in a time t, and D is the diffusion coefficient of the particle. Therefore, the 
time it takes the particle to travel over a distance is proportional to the square of that 
distance [139, 149]. The diffusive motion of a particle over large distances is negligible, 
but it can account for a significant portion of mass transport when considered on the 
micro-scale. An additional consideration is the relative amount of surface area exposure, 
which increases dramatically in a microfluidic device. This can cause increased heat 
conduction and faster diffusion. Therefore, the effect of diffusion becomes very 
important and must be accounted for in small volume devices.   
In a living cell, volume containment and material diffusion are controlled by the 
physical structure of the cell membrane. Therefore, mimicking the cell membrane must 
take into account the approaches that the membrane of a living cell uses to gate and select 
the types of molecules that are allowed to diffuse through it. The strategies used to 
convey gating abilities of a cell mimic device could be classified according to the desired 
type of selectivity, such as electrochemical, chemical or physical. Gating by 
electrochemical selectivity can be achieved by changing the surface charge of the channel 
walls by applying electric potentials. It can also be achieved by changing the surface 
charge of the molecule or species by controlling the ionic strength of the solution or by 
controlling the external pH. Strategies that use chemical selectivity can involve 
functionalizing the surfaces of the nanopores with a reactive molecule. Specific species 
will bind to the reactive molecule at the entrance of the nanopores to block or allow flow 
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through them. Physical selectivity can be achieved by decreasing or increasing the size of 
the membrane pores, thereby achieving a physical restriction of flow through the pores.  
The cell mimic device described here (Figure 2.1) uses physical selectivity for transport 
and mixing of materials across its membrane. During the transmembrane diffusion, the 
diffusivity (Do) of a specific molecular species depends on the viscosity of the medium in 
which it is suspended, the temperature of the medium and the hydrodynamic radius of the 
species. Effective diffusivity (Deff), also referred to as apparent diffusivity, can 
dramatically change based on binding interactions of the molecules with pore surfaces 
and steric hindrance of molecular motion. More dramatic changes to effective diffusivity 
(Deff) can occur by increases in pore length and reductions in pore radius, which translate 
into significant changes in pore surface area to open volume ratio. Effective diffusivity of 
a given molecule at the nanoscale level is also influenced by phenomena such as single 
file diffusion and ionic selectivity [157, 158]. The rate of molecular transport per unit of 
membrane area depends also on the size and number of pores (open volume fraction). It 
is the architecture of the membrane that enables functionality, therefore defining and 
implementing a strategy for tuning membrane permeability by controlling the physical 
pore width is the primary focus of this chapter. More specifically, we demonstrate 
functional size exclusion and molecular containment. Fluorescence recovery after 
photobleaching and a Lumped Capacitance Model are used for predicting transport 
measurements and transient changes in concentration within a nanoporous reaction vessel 
under moderate external flow.  
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Figure 2-1:  Scanning electron micrographs of containment vessels for assessing diffusive 
loss taken prior to filling and sealing show the integration of porous vessels within a 
microfluidic channel (left), the overall device size and pore locations (center) and 
nominal pore size (right). Images were taken at a 30° stage tilt. 
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2.2.  Materials and Methods 
 
2.2.1.  Microfluidic device fabrication 
 
The small volume reaction devices were fabricated as described in Retterer et al 
[159].  A 400 silicon wafer with a h100i crystal orientation was used to fabricate the 
devices. The etch mask for the reaction devices was defined by spin-coating the wafer 
with NANO PMMA 495 A4 electron beam resist (Microchem Corp., Newton, MA) at 
2500 rpm for 45 seconds and baking it on a hotplate for 10 min at 180° C. The geometry 
of the reaction container and optical alignment marks for subsequent processing were 
exposed using a JEOL JBX9300-FS electron beam lithography system operating at 100 
kV and 2 nA. The patterns were developed for 1 min in 1:3 methyl isobutyl ketone 
(MIBK):isopropyl alcohol (IPA), rinsed with IPA, and dried with nitrogen. Afterwards, 
they were exposed to a brief oxygen plasma (10 sccm, 150 mT, 100 W, 6 s) before 
depositing 15 nm of chromium via electron beam evaporation. Then the wafer was 
soaked in acetone, and rinsed with IPA and water. The rinsing leaves behind a chromium 
etch mask in the areas exposed by the electron beam. Conventional contact alignment 
optical lithography was then used to define the microchannel masks. The wafer was 
treated with MicroPrime MP-P20 (Shin-Etsu MicroSi, Inc., Phoenix, AZ), which was was 
spin-coated at 6000 rpm. JSR Micro NFR 016 D2 55cp (JSR Micro Inc., Sunnyvale, CA) 
was then used as the etch mask for the microchannels. It was also spin-coated at 6000 
rpm. NFR is a negative photoresist and it is more resistant to cracking during the 
cryogenic etching process. Next, the wafer was baked on a hotplate at 90°C for 90 
seconds, exposed, and baked for an additional 90 seconds at 90°C. CD26 (Microchem 
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Corp., Newton, MA) (<5% tetramethylammonium hydroxide) was used to develop the 
samples for 20 seconds, until the microchannels were visibly developed. The wafer was 
then rinsed with water, dried with N2 and baked for 3 min at 180°C.  To remove any 
organic solvent and resist residue left on the exposed silicon, the wafer was exposed to a 
brief oxygen plasma (10 sccm O2, 150 mT, 400 W, 1 min). Oxford Plasmalab 100 using a 
cryogenic silicon etching process was used to etch the wafer by exposing samples to a 
plasma of SF6 and O2 at 110°C. Reaction vessels and channels were etched to a depth of 
15 mm at a rate of approximately 3 mm/min. After cryogenic etching was completed, 
exposing the wafer to another oxygen plasma and briefly soaking it in chromium etchant 
removed mask materials. Oxford Plasmalab 100 plasma enhanced chemical vapor 
deposition system was used after the removal of the etch mask materials to deposit silicon 
dioxide on the structures. The duration of the deposition was 2, 4, 5, 6 and 7 minutes to 
control final pore dimensions and tune size selectivity of the nanoporous reaction vessels.  
The resulting silicon wafer contains eight identical chips. Each chip is 4 cm long and 
consists of 2 channels, each with an array of 18 reaction containers. The cylindrical 
container is 2 μm thick with 8 sets of 7 slits. Slits range in size from ~5-200 nm wide and 
10 μm deep [63, 159]. For the experiments described here, the container has a volume of 
~19 pL (Figure 2.2).  
2.2.2. Device packaging and general imaging techniques 
 
Polydimethylsiloxane (PDMS), prepared from a Sylgard 184 silicone elastomer kit (Dow 
Corning, Midland, MI), was used to seal the channels and the containers after devices 
were filled with the reaction components or different solutions. PDMS was mixed at a   
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Figure 2-2: Fabrication steps of the cell mimic device.  The fabrication of the silicon 
containment vessels is a top-down process that uses both electron beam and optical 
lithography.  (a) Electron beam lithography is used to define the vessel geometry 
including the overall size, pore structure and appropriate alignment marks.  (b) Contact 
lithography is used to define the larger microfluidic structures.  (c) A single cryogenic 
silicon etching process is used to transfer the two dimensional pattern into silicon.  
Masking materials are then stripped and the device is coated with a thin PECVD oxide to 
add additional control to pore size.  (d) A PDMS layer is added on top of the chip to 
enclose the system. 
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10:1 w/w ratio, degassed and cured for approximately 1 h at 70°C. Then, it was cut into 4 
mm thick pieces matching the microfluidic chip size. Holes were made at the ends of the 
channel for the inputs and output of the network using an 18-gauge blunt tip needle and 
fitted with tygon tubing and appropriate gauge needle and syringe. The packaged chip 
measured approximately 4 cm long by 15 mm wide. The number and type of individual 
reaction vessels can be modified from one chip to the next.  Each chip configuration 
consisted of two channels with 18 vessels in each of two channels, spaced at equal 
intervals along the channel. Each array of 18 devices can be imaged simultaneously in the 
viewing area of a Zeiss Axioscop epifluorescent microscope with a 10x objective. 
2.2.3. Loading of nanoporous reaction vessels 
 
Prior to sealing with PDMS, the chips were treated with a 1 mg/mL solution of bovine 
serum albumin for 60 min, to prevent nonspecific adsorption of reaction constituents to 
the device walls. An adapted cell microinjection system, which consists of a hydraulic 
manipulator with manual injection pump attached to a Burleigh micromanipulator was 
used to fill individual vessels. Pulled micropipettes with tip diameters of two microns 
(Small Parts Inc., Logansport, IN) were loaded with the desired reagent by backfilling 
them using a flexible polyimide needle (World Precision Instruments, Sarasota, FL).  
Chips were manually filled under a stereomicroscope by touching the filled pipette into 
the center of the reaction vessels. The amount of material injected in the device was 
dictated by the volume of the device structure and viscosity of the filling solution. For 
DNA containment experiments solutions contain 4% glycerol to reduce the risk of 
overfilling devices (Figure 2.3). 
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Figure 2-3: Nanoporous reaction devices are fabricated within microfluidic channels by 
combining electron beam lithography and metal lift-off techniques with contact 
photolithography to define the reaction vessel and channel geometries (top). The pattern 
is transferred into the exposed silicon using cryogenic silicon etching and individual 
vessels are filled with reactants via microinjection (middle). The entire chip is then sealed 
with PDMS (bottom) [159]. 
 
  33 
2.2.4. Bacterial growth and media 
 
E. coli strains BL21 (DE3) (Invitrogen) were grown in Luria-Bertani (LB) 
medium, which was supplemented with 50 µg/ml ampicillin since the plasmid used has 
an ampicillin resistance gene. E. coli cultures were grown at 37°C unless otherwise 
noted.  Plasmid DNA (5.4 kb) used in the DNA containment and labeling experiments 
was constructed by recombining a gene for enhanced GFP (EGFP) into pDEST17 
(Invitrogen) to allow expression of 6 His-GFP from a T7 promoter. The plasmid 
pDEST17 was transformed and propagated in chemically competent BL21 (DE3) 
(Invitrogen) cells. Briefly, transformation was conducted as follows. The pDEST17 
plasmid was thawed a room temperature and the BL21 (DE3) (Invitrogen) cells were 
thawed on ice. Then, 3 µl of plasmid was added to 100 µl of cells, which were then left 
on ice for 30 minutes. Afterwards, the cells were heat-shocked for 45 seconds at 42°C 
and put on ice for 2 minutes. The cells were then added to 400 µl of LB with ampicillin 
and placed at 37°C for 45 minutes under continuous shaking. About 200 µl was added in 
Petri dishes treated with ampicillin and were left to grow overnight. Colonies grown on 
these plates were later used to grow more cells for plasmid and protein purifications.  
Plasmid DNA was purified from the transformed Escherichia coli BL21 (DE3) cells 
(Invitrogen) using a Qiagen Plasmid Midiprep Purification kit (Valancia, CA) according 
to the manufacturer’s instructions.  
2.2.5. Protein purification and SDS-PAGE 
 
Production of EGFP was carried out using the plasmid described above to 
transform E. coli BL21 (DE3) cells. IPTG was added to a final concentration of 1 mM to 
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induce expression of 6 His-GFP. The transformed cells were grown at 30°C overnight 
and 0.5 ml of the overnight culture was used to inoculate 100 ml of LB media. The 
culture was incubated at 37°C until it reached an OD600 of 1.0. Cells were centrifuged for 
20 minutes at 5000 rpm and resuspended in 15 ml of BugBusterTM (Novagen) 
supplemented with 15 µl of 100 mg/ml lysozyme. Protein degradation was prevented by 
supplementing the samples with HaltTM protein inhibitor cocktail (Pierce Biotechnology, 
Rockford, IL) according to the manufacturer’s instructions.  The cell lysate was incubated 
at 4°C for 30 minutes and was sonicated (3 pulses, 30 second duration) with a Branson 
Digital Sonifier. The lysate was then centrifuged at 14,000 rpm for 30 minutes and the 
supernatant was applied directly to His-Select Nickel Affinity Gel column (Sigma, Saint 
Louis, MO). The column was then washed with 10 column volumes of wash buffer and 
eluted with 2 column volumes of wash buffer containing 500 mM imidazole.  
Dialysis was conducted to change the buffer from elution buffer to TRIS buffer. 
The purified EGFP was added to an Amicon Ultra-15 filter column (Millipore) to 
exchange the elution buffer with 20 mM of TRIS buffer since the imidazole that is 
present in the elution buffer degrades the protein after a few days of storage in -80°C. 
After the extraction procedure, both the insoluble and soluble fractions were boiled in 
sodium dodecyl sulfate (SDS) sample buffer and 5 µl was loaded on a 12% TRIS-HCl 
polyacrylamide gel (Bio-Rad) to test purity. The gel was electrophoresed for 1 hour at 
100V. The gel was stained with comassie blue stain overnight and destained with a 
methanol solution for 12 hours (Figure 2.4). 
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Figure 2-4:  SDS-PAGE of different concentrations of purified EGFP 
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2.2.6. Fluorescence Recovery After Photobleaching (FRAP) 
 
To evaluate the rate of transport of EGFP through the pores of the cell mimic 
device fluorescence recovery after photobleaching (FRAP) was conducted on devices that 
had undergone 4, 5, 6 and 7 minute duration of PECVD silicon dioxide deposition. The 
experiments were conducted by first filling the device and the microfluidic channel with 
6.6 µM EGFP. The experiments were performed on a Leica TCS SP2 scanning confocal 
microscope equipped with a Leica HCX PL APO 63X oil immersion objective lens. 
Leica LCS software (version 1537) FRAP application was used to collect pre-bleach, 
bleach and post-bleach images. Bleaching was performed with a 40 µm diameter circular 
region-of-interest (ROI), which corresponds to the size of the cell mimic device. The 
bleach pulse was applied by setting the 488-nm line of a 25 mW argon-krypton laser to 
acousto-optic tunable filter (AOTF) of 100%. Fluorescence recovery was measured at an 
AOTF of 2-3% laser power. All the parameters of the FRAP experiments are briefly 
described as follows. 1) Select “GFP” reading. 2) Switch microscope control from visual 
to scan. 3) Set Pinhole to 250. 4) Set Beam expander to 3. 5) Set Format 256 x 256. 6) Set 
Mode xyt. 7) Set speed 1000 Hz. 8) Set laser bleach intensity to 100%. 9) Set pre-bleach 
images to 3. 10) Set bleach to 150 laser pulses and post-bleach to 200 laser pulses. 11) 
Set laser intensity for image to 3% of bleach. 
2.2.7. Functional demonstration of size exclusion and molecular containment 
 
To demonstrate the functional size range for exclusion using the 200 nm pore 
devices, microchannels were loaded with solutions of 100 nm and 350 nm Fluorsbrite  
latex beads at a flow rate of 10 µL/h.  Care was taken to insure that air bubbles were not 
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trapped in the reaction vessels. Fluorsbrite  100 nm and 350 nm latex beads used in size 
exclusion experiments were obtained from Polysciences Inc. (Warrington, PA). Images 
were taken every 5 minutes for 1 hour. 
DNA containment and labeling experiments were carried out by filling reaction 
vessels with DNA concentrations ranging from 30 to 240 ng/µL in buffer. A labeling 
solution consisting of ethidium bromide (EtBr) at a concentration of 100 µg/mL was 
injected into the microchannel. Images were captured before adding EtBr, immediately 
after adding EtBr, and after 30 min under flow at a flow rate of 10 µL/h. Ethidium 
bromide and other reagents were purchased from Sigma Aldrich. 
2.2.8. Containment of fluorescein and EGFP 
 
 Flow experiments were conducted by first filling the reaction vessels with a 100 mg/mL 
solution of fluorescein and different EGFP concentrations. Under a steady flow of 10 
µL/h ensembles of reaction vessels were imaged. A Retiga firewire camera and QCapture 
software were used to capture fluorescent and bright field images. Care was taken to 
ensure that exposure times, binning and other relevant camera settings were maintained 
to allow reasonable comparisons to be made between experiments. A shutter was used to 
minimize photobleaching when images were not being captured.  
 
2.3. Results and discussion 
2.3.1. Device fabrication 
 
A combination of optical and electron beam lithography were used to achieve the 
desired device geometries and fabrication. Eight chips were completed per wafer using 
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batch fabrication. Multiple wafers could be produced due to the relative short electron 
beam lithography write time (~45 min per wafer). Completed cell mimic devices had an 
inner diameter of 40 microns, a 2 µm thick wall, and 56 pores (8 sets of 7 pores). 
Structures and channels were 15 µm tall, with heights measured using physical 
profilometry. The internal volume of the structures was approximately 19 picoliters. A 
diameter of 40 µm was chosen because of the relative ease with which the devices could 
be imaged and filled using microinjection (Figure 2.2 and 2.3).  
2.3.2. Fluorescence Recovery After Photobleaching (FRAP) 
 
 Fluorescence Recovery After Photobleaching (FRAP) has been an important 
technique in determining diffusion of fluorescently labeled proteins across the cell 
membrane. With this technique, a high intensity pulse is used to photobleach an area of 
the cell and the movement of unbleached molecules from surrounding areas into the 
bleached area and vice versa is recorded by time-lapse microscopy. The idea behind this 
method is to measure the ability of a fluorescent molecule to move around over time. The 
diffusion coefficient (D) of the fluorescent protein is related to both its rate and extent of 
recovery (Figure 2.5a). FRAP has been widely used to help define the fluid mosaic model 
of cell membranes and to measure the lateral diffusion of various membrane or 
cytoplasmic constituents. It has also been used to determine if a protein is able to move 
within a membrane. Simulating a mathematical reaction-diffusion model and deriving the 
diffusion coefficient and binding or dissociation constants by parameter estimation, is the 
best approach towards a quantitative interpretation of FRAP data [160, 161].    
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Figure 2-5:  Fluorescence Recovery After Photobleaching. (a) Presentation of data 
collected during a FRAP experiment. Fluorescence is collected before and after 
photobleaching occurs. Over time, the unbleached molecules diffuse into the 
photobleached area and the amount of fluorescence increases [161].  (b) Fluorescent 
recovery of reaction vessels with different nominal pore sizes. 
 
a. 
b. 
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 Here, FRAP has been adapted to measure the rate of EGFP fluorescence recovery 
over time within the reaction device. This provides a measurement of diffusion of eGFP 
through the pores of cell mimic devices that have undergone 4, 5, 6 and 7 minute duration 
of PECVD silicon dioxide depositions. Fluorescence recovery occurred in all the devices 
(Figure 2.5b).  In order to fit the recovery data with a mathematical diffusion model, a 
Matlab (The Math Works, Natick, MA) code is being written by a staff scientist at ORNL 
and it is still an ongoing process.  
2.3.3. Functional demonstration of size exclusion and molecular containment 
 
In separate experiments, 100 and 350 nm beads were injected into microfluidic 
channels containing cell mimic devices with 200 nm pores. 100 nm beads easily entered 
the vessels while 350 nm beads were excluded. Figure 2.6 demonstrates that vessels have 
a functional pore size, and size distribution between 100 nm and 350 nm.  
 In DNA labeling experiments 240 ng/µL, 120 ng/µL, 60 ng/µL and 30 ng/µL of 5.4 
kb plasmid DNA were loaded in reaction vessels using a microinjection system. DNA 
containment experiments were carried out in reaction vessels with a 200 nm pore and 
minimal silicon oxide coating. The cell mimic device was successful in containing the 
DNA while allowing small molecules to cross the reactor membrane and intercalate the 
DNA.   A fluorescent response proportional to DNA concentration (Figure 2.7) was 
apparent in images taken 30 min after ethidium bromide was introduced through the 
microfluidic channel. A limited degradation of the fluorescent signal was observed over 
time indicating that the DNA was contained within the reaction vessels over extended 
periods. 
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Figure 2-6:  Fluorescent polystyrene beads were introduced into microchannels at modest 
flow rates. (a) 100 nm diameter beads diffused through the reaction vessel membrane as 
expected, while larger (b) 350 nm beads were excluded. 
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Figure 2-7:  Plasmid DNA was loaded into reaction vessels with a minimal silicon 
dioxide coating at different concentrations (240 ng/µL – 30ng/µL) corresponding to the 
total mass shown.  Plasmid DNA was labeled in situ with ethidium bromide. 
Fluorescence was evident immediately and did not diminish, indicating that plasmid 
DNA is retained, and small molecules are able to traverse the membrane and react with 
the plasmid. 
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A 5.4 kb plasmid has a computationally and experimentally predicted radius of 
gyration between 80 and 240 nm [162, 163]. This suggests an overall diameter that 
fluctuates near the value that is the width of the pore (200 nm). The absence of 
fluorescent material outside of the vessels and the persistence of fluorescence from the 
labeled DNA after 60 min indicate that the plasmid is not able to freely diffuse through 
the reaction vessel membrane. Ultimately, to control the transport of specific proteins or 
small molecules across and between reaction vessels, the pore size and surface charge or 
functionality would need to be tuned further. Therefore, we examined the use of plasma 
enhanced chemical vapor deposition to reduce pore size (width) and limit the flux of 
molecules such as fluorescein and EGFP across the vessel membranes. Individual chips 
containing devices were subjected to different durations PECVD silicon dioxide 
depositions. Plasma enhanced chemical vapor deposition can further change the width of 
the pores by depositing thin films of silicon dioxide from the gas state into the solid state 
on the device. The longer the device undergoes this procedure, the greater the oxide is 
deposited and the smaller the width of the pores becomes. Since there is a considerable 
reduction in pore size as more silicon dioxide is deposited on the reaction vessels (Figure 
2.8), it would be difficult to directly measure the effective gap size through the entire 
thickness of the membrane using imaging techniques. Therefore, the effect of silicon 
dioxide deposition on pore size can be indirectly assessed by measuring the retention 
of GFP (~30 kDa) and fluorescein (~300 Da). A comparison of retention of different size 
proteins such as GFP and fluorescein within devices that have different amounts of 
silicon dioxide depositions was carried out. Individual device chips were subjected to 4, 
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Figure 2-8:  The deposition of silicon dioxide on membrane structures can be used to 
reduce pore width.  Pores are shown after (a) 2, (b) 4, (c) 6, and (d) 8 min of PECVD 
silicon dioxide deposition. The retention of green fluorescent protein was observed after 
5 min in reaction vessels coated with silicon dioxide for (e) 4 min (100 ms digital camera 
exposure) and (f) 6 min (50 ms digital camera exposure). Each of the devices shown was 
filled with the same concentration of EGFP. 
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5, 6, and 7 minute duration of PECVD silicon dioxide depositions.  The fluorescein and 
EGFP diffusion experiments (Figure 2.9) showed a quick diffusion of both molecules out 
of devices that have 4 and 5 minute duration of PECVD silicon dioxide depositions. 
Devices with 6 and 7 minute PECVD retained GFP and fluorescein much longer.   
Based on Fick’s law, a Lumped Capacitance Model for predicting transient 
changes in concentration within a nanoporous reaction vessel under moderate external 
flow was prepared and used to fit the fluorescein and eGFP diffusion data (Figure 2.10). 
This module was used to determine the effective gap size of devices that were subjected 
to 4, 5, 6, and 7 minute duration of PECVD silicon dioxide deposition.  The following 
assumptions were made for this model: a) External concentration of the species diffusing 
from the device is effectively zero since the channel is under a continuous flow. b) The 
solution inside the cell mimic device is well mixed and c) The change in concentration 
across the nanoporous membrane of width Δx is assumed to be linear.   
 Using Fick’s law, the rate of mass (m) loss from the reaction vessel can be 
expressed as follows: 
 
 
 
D is the diffusivity of the species of interest (fluorescein or EGFP), n is the number of 
pores, Mw is molecular weight, Apore is the cross sectional area of a single pore  and is the 
product of the pore height and width  (hpwp), C is  concentration and x is the thickness of 
the membrane.  Discretizing this expression based on the assumptions enumerated above   
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Figure 2-9:  Diffusion of EGFP and fluorescein on cell mimic devices that have 
undergone 4, 5, 6 and 7 minute PECVD. (a) Diffusion of GFP.  (b) Diffusion of 
fluorescein. The graphs represent the average intensity recorded from 3 individual 
reaction containers during 3 separate diffusion experiments.  Error bars representing +/- 
one standard deviation are shown at 1 minute intervals for clarity. 
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Figure 2-10: Lumped Capacitance Diffusion model (a) EGFP and (b) fluorescein for 
predicting transient changes in concentration within the cell mimic device with different 
pore widths of 35, 25, 13 and 9 nm under moderate external flow.  
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for a short time increment Dt, the change in concentration can be expressed as: 
 
 
 
where V is the total volume of the reaction vessel.  Using the above equation and noting 
that the concentration outside of the vessel is assumed zero, the following expression can 
be written for the concentration within the vessel at t+Dt.  
 
 
 
or 
 
 
 
Therefore the concentration within the vessel for an arbitrary time t+kDt can be given as: 
 
 
 
This final equation was used to calculate the predicted normalized concentration within 
porous reaction vessels for a desired period of time.  The cell mimic dimensions were 
15µm high, 40µm diameter, 2µm membrane thickness, and literature based diffusion 
coefficients for fluorescein and EGFP were 1.6 * 10-10 m2/s and 1.0 * 10-11 m2/s 
respectively [164, 165].  The 56 slit-shaped pores were estimated to be 10µm deep.  
Graphs of concentration over time were calculated using a time step of 10 seconds and 
different pore size widths for expected diffusivities for fluorescein and EGFP [159].  
Comparing the experimental diffusion data of EGFP and fluorescein on devices that were 
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subjected to 4, 5, 6, and 7 minute duration of PECVD silicon dioxide depositions, with 
the diffusion model based on different pore size widths, we determine that 4 minute 
PECVD corresponds to ~35 nm pore width, 5 minute PECVD corresponds to  ~25 nm 
pore width, 6 minute PECVD corresponds to  ~13-15 nm pore width and 7 minute 
PECVD corresponds to  ~5-10 nm pore width (Figure 2.11). EGFP has a cylindrical 
shape with axis lengths of 2.4 and 4.2 nm; therefore a 7 minute PECVD device with a 
calculated pore width of ~5-10 nm should predominantly retain the protein when 
compared to shorter durations of PECVD. However, the comparable size of the 7 minute 
PECVD pore and eGFP may also lead to clogging of the pores as time progresses. 
2.4. Conclusions 
 
 The results presented in this chapter show that nanoporous, cellular-scale reactors 
can be created and modified using multi-scale fabrication techniques such as electron 
beam and contact lithography, cryogenic etching and plasma enhanced chemical vapor 
deposition. Size modification of the device pores can allow for the retention of larger 
species that represent information or functionality within a reaction system while 
allowing smaller materials to freely pass through the porous membrane. Such reaction 
vessels may prove useful in fundamental studies of protein-based complex reaction 
systems and will enable the development of responsive sensors and therapeutic platforms 
that rely upon the on-demand conversion or production of biological materials. The 
concepts of controlled flux and scaled transport presented in this aim can drive the design 
of synthetic reaction vessels, which will then lead to more complex systems and networks 
such as single and coupled enzyme reactions and cell-free transcription/translation.  
  50 
  
 
 
 
 
 
 
Figure 2-11:  Experimental diffusion data vs. the diffusion model.  a) Normalized EGFP 
diffusion data for devices that have undergone 4, 5, 6 and 7 minute PECVD vs. the 
diffusion model for pore widths of 35, 25, 13 and 4 nm. b) Normalized fluorescein 
diffusion data for devices that have undergone 4, 5, 6 and 7 minute PECVD vs. the 
diffusion model for pore widths of 35, 25, 13 and 9 nm. 
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Chapter 3  
Enzymatic reactions in nanoporous, picoliter volume 
containers 
 
This chapter is based on a manuscript about to be submited to  Analytical Chemistry, 
Siuti, P.; Retterer, S.T.; Chang Kyoung Choi and Doktycz, M.J., "Enzymatic reactions in 
nanoporous, picoliter volume containers,"  
 
Data, images, and text relevant to this study are included in this chapter. Images are 
presented in color where they were published in black and white. Under the direction of 
the co-authors, I conducted the experiments, analyzed the resulting data, and drafted the 
manuscript. The co-authors responded with editorial comments and additional text where 
needed. 
 
3.1. Introduction 
 
Enzymes are responsible for catalyzing and increasing the reaction rates of almost 
all chemical reactions that occur inside and outside a cell, which makes them important 
for understanding biological interactions at the molecular level [166]. They have and 
continue to play a key role in biological sensing and information processing. Our 
understanding of enzymes has improved rapidly in the past decades, and extensive 
studies have been done to explain rate enhancements by enzyme catalysis[167]. In 
combination with structure determination and genetic engineering, many new approaches 
and biochemical methods have also been developed. They have provided more details 
about enzyme reaction mechanisms such as charge stabilization and turnover rates [168, 
169]. However, there is still more to discover about enzymes mode of action, structural 
interactions, analytical capacity and sensitivity. A main challenge for reaching this goal is 
that biocatalyst optimization and analysis is limited by the impracticalities of 
conventional enzyme screening techniques due to sample consumption, inability to 
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remove inhibitory byproducts and the number of experiments that need to be 
performed[170]. Therefore, different approaches that allow for faster screening of 
enzyme reactions, small sample consumption and mimic the natural small volume and 
crowded conditions of biological cell compartments are necessary. 
Advances of micro and nanotechnology have enabled engineering of systems at 
the scale of biological cells [171], which has led to a rapid growth in the field of micro-
total analysis systems (µ-TAS) and enzyme microreactor engineering[172]. Recently, 
several small volume reaction containers have been created in different materials, shapes 
and pore sizes such as liposomes [173-176], water in oil (w/o) emulsions[5], nanoliter 
wells defined in polydimethylsiloxane (PDMS) [177, 178], and hydrogel-based 
microreactors [179]. These small volume devices can relieve the need of structures for 
mixing, decrease the number of molecules required for carrying out a reaction, decrease 
analysis time and rapid heat exchange when compared to traditional analytical systems 
[124]. They can also be modified to control the flux of different size molecules and 
facilitate kinetic studies, help in analysis of the affinity and action of enzymes toward 
new drug candidates, and offer the potential to screen hundreds of combinations of 
enzyme and substrates in a parallel way [125-128].  
Most of the efforts for designing microdevices for biosensing and studying 
enzyme kinetics have focused on miniaturizing batch mode reactors or microreactors that 
operate in a continuous mode by immobilizing enzymes on a solid support [128].  
Miniature batch mode reactors have been used in a variety of approaches. Mao et al 
developed a technique for creating multiple batch microreactors in micrometer-size glass 
capillaries or in microfabricated channels. They used the batch microreactors to study 
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enzyme kinetics under different values of temperature and/or pH [180]. Jung et al 
developed polydimethyl siloxane (PDMS) femtoliter-scale chambers for studying single-
molecule enzyme kinetics and sensitivity [181]. However, miniaturized batch reactors 
have drawbacks such as their inability to remove inhibitory byproducts and the “dead 
time”, which is the time it takes the reactant to mix before kinetic data are collected 
[128]. Microreactors that operate in a continuous mode have addressed most of the 
shortcomings of the batch reactors by removing inhibitory byproduct build up, reactor 
dead time and reducing material consumption. The initial practice of such small volume 
containers and microfluidic systems for analyzing enzyme kinetics was based on the 
transportation of reagents and samples through a system of micrometer dimension 
channels with electrokinetic flow for controlling dilution and mixing. This approach has 
demonstrated a 4-fold reduction in enzyme and substrate consumption over conventional 
methods [182]. Burke et al conducted a stopped-flow enzyme assay using a 
microfabricated mixer, which consumed 6 nL enzyme and was completed in 60 s [183]. 
Later, other approaches have been developed such as centrifugal microfluidic system 
which could carry out enzymatic assays through colorimetric detection [184], and the 
usage of immobilized enzymes within or on microchannels for a continuous and stopped-
flow analysis of enzyme kinetics [124, 128, 185-188]. These approaches have allowed for 
automation of enzymatic assays and for reduction of time and reagent consumption. 
However, there are still drawbacks for microreactors operating under continuous flow. 
Such drawbacks include better control of the flux of different size molecules and 
recovery of the enzyme requires extra steps for separation of unreacted substrate and 
product from the enzyme solution [128]. Immobilizing enzymes onto solid surfaces can 
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also be a drawback since it can damage the structure of the enzyme, thus leading to 
potential alteration of the intrinsic kinetic rates or loss of activity [124]. Many of these 
shortcomings can be addressed by designing devices with pores small enough to contain 
the enzymes inside and remove the inhibitory byproducts, while operating in a 
continuous mode. Such a device is capable of communicating and exchanging chemical 
information with its surroundings. 
Reported here is a nanoporous, picoliter reaction container within a microfluidic 
channel (Figure 3.1), which operates under a continuous flow system and has been used 
as a new strategy for the microscale analysis of enzyme kinetics. Individual properties of 
the device such as volume (19 pL) and pore size (~10 nm) can be controlled and allow 
for a defined flux of reagents, better diffusional mixing, and for enzymes to be trapped 
inside the device in their native form. The device has been used to conduct single and 
coupled enzyme reactions of horseradish peroxidase (HRP) and glucose oxidase (GOX) 
with amplex red substrate to monitor different glucose concentrations under a continuous 
flow system. Real-time monitoring of glucose and hydrogen peroxide catalysis within 
single and array reaction devices was performed and showed better sensitivity than 
macroscale methods. The picoliter container presented here has great potential to be used 
as a plaform for designing and fabricating biosensors. It can also be used for many 
analytical applications such as studying biochemical reactions and the effects of scale on 
reaction efficiency, screening of substrates, and a continuous-flow analysis of enzymes 
and their kinetic characteristics.  
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Figure 3-1: A nanoporous, picoliter volume platform for enzyme reactions.  (a) SEM 
micrograph of a microfluidic device with an array of 18 reaction containers. The inset 
SEM micrograph shows a single reaction container.  The slits have a limiting aperture of 
10 nm. (b) Schematic of a nanostructured reaction container where glucose oxidase, 
along with horseradish peroxidase, is loaded into the device using a micromanipulator. 
(c) Schematic of a nanostructured reaction container is shown in operation. The 
microfluidic channel and device are sealed with PDMS. The channel is used to 
continuously deliver glucose and amplex red and remove resorufin and inhibitory 
biproducts from the reaction chamber to facilitate coupled enzyme reactions. 
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3.2. Materials and Methods 
3.2.1. Microfluidic device 
The small volume reaction devices were fabricated as previously described in 
chapter 2 and in Retterer et al [159]. The resulting silicon wafer contains eight identical 
chips. Each chip is 4 cm long and consists of 2 channels, each with an array of 18 
reaction containers (Figure 3.1). The cylindrical container is 2 μm thick with 8 sets of 7 
slits. Slits range in size from 5-200 nm wide and 10 μm deep [63, 159]. For all 
experiments described here, the container has a volume of ~19 pL. 
3.2.2. Single Enzyme Reaction 
Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Invitrogen A22188) was used 
for enzyme reaction experiments according to manufacturer’s directions.  Prior to the 
experiments, the inner walls of the reaction device were treated with 1 mg/mL Bovine 
Serum Albumin (BSA) in PBS for 60 min to prevent nonspecific absorption of reagents 
to the surface of the device.  
The solution containing 5 µM hydrogen peroxide (H2O2) and several horseradish 
peroxidase (HRP) concentrations of 0.0125u/ml, 0.025u/ml, 0.5u/ml and 1u/ml was 
mixed in a 1:1 ratio with 20 % glycerol and loaded into a glass micropipette with tip 
diameter of 2 μm (World Precision Instruments, TIP2TW1), using a flexible polyimide 
needle (World Precision Instruments). The cell mimic device was filled by touching the 
tip of the glass micropipette into the center of the device and the amount of solution 
injected depended on the viscosity of the solution. Several mimics were filled with only 
0.0125u/ml, 0.025u/ml, 0.5u/ml and 1u/ml HRP and were used as negative controls. After 
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the small volume containers were loaded, the chip was covered with a 5 mm thick layer 
of polydimethyl siloxane (PDMS), which was used to seal the device. 
Sylgard 184 silicone elastomer kit (Fischer Scientific) was used to prepare PDMS. 
Sylgard 184 silicon base and the curing agent were mixed in a Petri dish at a 10:1 w/w 
ratio, respectively. The mixture was degassed for ~30 min and cured in the oven at 70°C 
for 60- 90 minutes. After baking, PDMS was cut into pieces covering the chip and two 
holes were punched on each end of the channel using an 18 gauge blunt tip needle. 
Polyethylene tubes were fit into the holes to allow for the input and output of solutions in 
and out of the channel. The channel was then filled with working solution and kept at a 
constant flow of 1µL/hr, 5µL/hr and 10µL/hr. The working solution consists of 100 µM 
Amplex Red, 0.05 M sodium phosphate pH 7.4 and 10% glycerol. The experiments were 
conducted at room temperature and repeated a minimum of three times.  
A resorufin standard was prepared by diluting different concentrations of 1, 2, 3, 
4, 5, 6 and 7 µM resorufin (Figure 3.2). Each of the eGFP solutions contained 10 % 
glycerol concentration. These solutions were loaded in devices and fluorescence was 
measured using identical settings as for single and coupled enzyme reactions. Resorufin 
concentration produced in the single and coupled enzyme reactions conducted in the cell 
mimic devices was measured against this resorufin standard. 
 
3.2.3. Coupled Enzyme Reaction 
Amplex Red Glucose/Glucose Oxidase Assay Kit (Invitrogen A22189) was used for 
coupled enzyme reaction experiments according to manufacturer’s directions.   
 
A 
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Figure 3-2:  Resorufin standard curve. A standard curve showing the fluorescent intensity 
according to the resorufin concentration in the device. Error bars are ±1 SD. 
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A similar procedure was also followed for coupled enzyme reactions. Bovine Serum 
Albumin was used to treat the chip for ~10 min prior to the experiment for preventing 
nonspecific absorption of reagents to the device. In this case the solution containing 0.5 
u/mL glucose oxidase (GOX) and 0.5 u/mL horseradish peroxidase (HRP) was mixed in 
a 1:1 ratio with 20 % glycerol which led to a final concentration of 0.25 u/ml GOX and 
HRP and 10% glycerol. The solution was then loaded into the device using a 2 μL glass 
microtip (World Precision Instruments, TIP2TW1). Several devices were filled with only 
0.25 u/mL HRP or GOX and used as negative controls. The chip was then covered with 
PDMS and the channel was filled with working solution at a constant flow rate of 
10µL/hr. The working solution consists of 100 µM Amplex Red, 1x buffer, 10% glycerol 
and 0.01, 0.1, 1, 5, 10 and 100 µM glucose.  
The coupled enzyme reactions were conducted on devices that had undergone 
different plasma enhanced chemical vapor deposition (PECVD) times of 2, 4, 6, 7 and 9 
min, which affects the size of the slits of the device. Several GOX and HRP enzyme 
concentrations of 0.0125u/ml, 0.025u/ml, 0.5u/ml and 1u/ml were tried in order to 
optimize the enzyme ratio. 
The experiments were also conducted with different substrate concentrations of 
10 µM, 100 µM, 1mM, 5 mM, 10mM and 100mM. Devices that had undergone 7 min 
PECVD were chosen to continue the rest of the experiments. They were loaded with a 
final 0.25 u/mL GOX, 0.25 u/mL HRP and 10% glycerol. The channel was then filled 
with working solution, which consisted of the various glucose concentrations, 100 µM 
Amplex Red, 0.05 M sodium phosphate pH 7.4 and 10% glycerol. Each experiment was 
repeated in triplicates for statistical purposes. 
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In order to compare coupled enzyme reactions in the device with conventional 
scale, coupled enzyme reactions were also conducted in a Costar 96 flat bottom well 
plate. The enzyme and substrate concentrations were kept the same as in the device 
reactions and the final reaction volume in the plate well was 100 μL. To ensure proper 
mixing of the reagents, the plate was shaken before each reading by the plate reader. 
Fluorescence was measured every 10 seconds using a Perkin Elmer HTS 7000 Plus 
BioAssay Reader. Each experiment was repeated in triplicates for statistical purposes. 
3.2.4. Imaging and data analysis 
Immediately after the channel was filled with working solution, fluorescence was 
monitored by measuring the intensity from time lapse images taken every 10 seconds 
with binning 1x1 and exposure time of 256ms. A Zeiss Axioskop 2 FS Plus 
epifluorescent microscope equipped with a Retiga firewire camera and a 40x dry 
objective (Zeiss) was used to obtain the images. A 200 W mercury arc lamp was used as 
light source for excitation. The Retiga firewire camera was synchronized with a Lambda 
SC smart shutter (Sutter, CA) and the proper filter sets were used to minimize 
photobleaching of resorufin during the experiments. The images were acquired as 16-bit 
grayscale TIFFs using acquisition software IPLab 4.0.8 (Scanalytics,Inc.). Camera 
settings, exposure times and binning were kept the same for all the experiments in order 
to allow comparisons between experiments. Image intensity values for each of the 
devices were calculated and plotted using MATLAB (V7.2, MathWorks).  
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3.3 Results and Discussion 
 
Understanding the countless interactions carried out by enzymes and their 
influence in a variety of fields such as biosensors, drug discovery, medical diagnostics 
and organic synthesis has been an immense challenge. Addressing this challenge requires 
methods with high-throughput capacity, which can be used for fast screening and 
identification of biocatalysts, inhibitors and drug targets. Microfluidic enzyme reactors 
have been emerging as a valuable tool by reducing the scale of reactions and as fast 
analytical procedures. Microfluidic technology is especially well suited for small-scale 
analysis since it can be integrated with optical sensing methods and has the potential to 
be introduced into industrial-scale synthesis. The nanoporous, container described here 
enables single and coupled enzyme reactions in picoliter volumes while enabling 
substrate exchange and inhibitory byproduct removal.  
3.3.1. Single Enzyme Reactions 
 
To test the ability of the picoliter volume reactor to carry out enzyme reactions, 
effective experimental conditions for filling the devices and carrying out the reactions 
were first determined. Several difficulties such as overflowing, quick sample drying and 
air bubble formation were encountered while loading the device. These difficulties, 
which were due to the small volume of the container (~19 pL) and the low viscosity of 
the reaction mix, were overcome by examining the effects of loading different ratios of 
reaction mix with glycerol. Glycerol is more viscous and takes longer to evaporate than 
the reaction mix. A new reaction mix consisting of 10% glycerol was found to be 
optimal. It had an increased viscosity, which made it easier to load the device, avoid air 
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bubble formation, and reduce the effects of evaporation before sealing the device with 
PDMS. Arrays of up to 18 devices could be prepared in this manner and only a brief 
amount of time (~20 minutes) was needed to prepare the reaction mix, load the device 
and begin measurements.  
Enzyme reactions are involved in all processes related to the physiological functioning of 
a cell. Enzymatic assays are important in many applications such as glucose sensing and 
monitoring, drug discovery and screening. High-throughput analysis of kinetic reaction of 
libraries of small molecules with specific enzymes is important for drug discovery and 
development, whereas screening of the activity of multiple enzyme mutants with a 
specific substrate is necessary for biocatalyst optimization [128]. Single enzyme reactions 
were conducted for the purpose of evaluating the efficacy of the device and for 
determining effective reaction conditions and qualitative assessment of the slits. Single 
enzyme reactions were successfully carried out on devices that had undergone different 
PECVD times. Amplex Red had penetrated through the slits of the device and was 
converted from colorless into red color by HRP in the presence of H2O2.  Flow rates of 1, 
5, 10 and 20 µL/hr were examined and 10 µL/hr was found to be optimal. Slower flow 
rates were not fast enough to remove all the resorufin that was observed diffusing out of 
the devices and the channel would fill with red color. 
Enzyme concentration present in the device did not affect the success of the 
experiment since the containers turned red under all enzyme concentrations. However, it 
took a longer time for the devices to turn red when smaller enzyme concentrations were 
present. Resorufin diffused out of the container quickly and filled the channel in red color 
for enzyme reactions conducted on 2, 4 and 6 min PECVD devices (Figure 3.3), whereas   
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Figure 3-3: Single enzyme reactions on 4 minute PECVD devices. 
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7 and 9 min PECVD devices had no visible product diffusion, which combined with 10 
µL/hr flow rate made it hard to detect and the channel remained colorless. 
As shown in the previous chapter, since PECVD of silicon dioxide is used to 
further change the width of the slits by depositing thin films of silicon dioxide from the 
gas state into solid state on the device, the longer the device undergoes this procedure the 
smaller the size of the slits becomes. Therefore, the 2, 4 and 6 min PECVD devices have 
bigger slits than the 7 and 9 min PECVD devices and allow molecules such as glucose, 
amplex red, H2O2 and resorufin to diffuse quickly through the membrane. Devices that 
have undergone 7 and 9 min PECVD have slits with smaller widths (~5-10 nm), therefore 
they can allow slow diffusion of small molecules such as glucose, amplex red, H2O2 and 
resorufin, but prevent large molecules such as horseradish peroxidase from transporting 
out of the device. Since the 7 min PECVD device was able to contain the reaction, we 
decided to continue the rest of the experiments using this type of device.  
3.3.2. Coupled Enzyme Reactions 
 
Coupled enzyme reactions were successfully conducted in the small volume 
containers. Glucose and amplex red penetrated through the slits of the device and glucose 
was converted by GOX in the presence of oxygen into gluconolactone and hydrogen 
peroxide. The newly formed H2O2 reacted with Amplex Red in the presence of HRP to 
form the molecule Resorufin, which was visible due to its fluorescent red color (Figure 
3.4 and 3.5). All reactions conducted with different enzyme concentrations were 
successful in the 7 and 9 minute PECVD coated devices (Figure 3.6).  
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Figure 3-4:  Sealed device and an array of enzyme reactions conducted simultaneously. 
Parallel reactions with a series of enzyme concentrations from 0.0125u/ml to 1u/ml in the 
devices and 10 mM glucose in the channel. 
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Figure 3-5:  Coupled enzyme reactions on 7 minute PECVD at (a) 10 minutes (b) 70 
minutes. 
a b 
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Figure 3-6:  Coupled enzyme reactions with 0.25 U/ml GOX and different HRP 
concentrations in cell mimic devices.  A) Coupled enzyme reactions on devices that have 
undergone 7 min PECVD. B) Coupled enzyme reactions on devices that have undergone 
9 min PECVD. Each graph represents the resorufin concentration, corresponding to the 
observed fluorescence intensity, from three coupled enzyme reaction experiments (3 
individual devices on 3 separate chips). Error bars represent +/- one standard deviation 
and are shown at 20 second intervals for clarity. 
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All reactions conducted with different enzyme concentrations were successful in 
devices that had undergone 7 and 9 minute PECVD (Figure 3.6). Devices that have 
undergone 7 min PECVD have slits with bigger widths (~5-10 nm) than the 9 minute 
PECVD devices, therefore they can allow a faster diffusion of small molecules such as 
amplex red, H2O2 and resorufin, but are still small enough to prevent large molecules 
such as glucose oxidase and horseradish peroxidase from transporting out of the device. 
Since the 7 min PECVD device was able to contain the reaction, we decided to continue 
the rest of the experiments using this type of device. GOX and HRP concentrations of 
0.25 u/mL were arbitrarily chosen to continue the rest of the experiments since these 
concentrations had results with the smallest error bars. 
Coupled enzyme reactions were also conducted with different glucose 
concentrations and showed to be substrate dependent (Figure 3.4 and 3.5). Higher 
glucose concentration increased the enzyme reaction rate in the device. The reaction 
reached its peak of 7-8 µM resorufin within ~150 seconds when glucose concentration 
was 100 mM and it took ~10 minutes when glucose concentration was 10 µM (Figure 
3.7). The coupled enzyme reactions conducted in the plate reader, reached the peak of 6 
µM resorufin within ~300-400 seconds for the high concentrations of glucose and it took 
~30-40 minutes when glucose concentration was 100 and 10 µM (Figure 3.7). Since there 
is a 1:1 stoichiometry ratio between H2O2 and the appearance of resorufin, the turnover of 
H2O2 could be determined from calibration curves obtained from the corresponding 
fluorescence intensities of known concentrations of resorufin.  
Enzyme kinetics were determined by measuring resorufin’s fluorescence signal 
through time in the device, and Michealis-Menten equation was used to evaluate enzyme  
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Figure 3-7:  Fluorescently measured coupled enzyme reactions in picoliter volume 
reactors and plate reader with glucose concentrations from 10 µM to 100 mM. Time 
course fluorescence intensity of the product resorufin according to the increase of the 
substrate concentration of glucose. 
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kinetics of the coupled enzyme reaction. Since this is a coupled enzyme reaction and 
glucose oxidation is the slowest reaction step, the overall reaction rate corresponds to the 
catalytic rate of glucose oxidase.  
V0 = Vmax[S]/(Km + [S]) 
 
In this equation, V0 is the initial rate of the enzyme reaction, [S] is the substrate 
concentration, Vmax is the maximum rate which corresponds to the velocity of the reaction 
when the enzymes are saturated with substrate, and Km is the amount of substrate needed 
for half the maximal velocity.  Maximal velocity (Vmax) was determined for each glucose 
concentration from the slopes of normalized fluorescence intensities as a function of 
time. Background fluorescence was measured for each reaction and then was subtracted 
from the fluorescence intensity measured in the device. 
Using the rates calculated from the data in Figure 3.7, a Lineweaver-Burk plot of 
1/V and 1/[S] was used to derive Km and Vmax (Figure 3.8).  
 
1/V0 = (Km/Vmax)/[S] + 1/Vmax 
 
 
 
The slope of the line for the Lineweaver-Burk plot is Km/Vmax, the Y intercept is 1/Vmax 
whereas the X intercept is -1/Km Coupled enzyme reactions in the device had a Km = 1.65 
± 0.17 mM and a Vmax = 67 ± 1.5 µM min-1, whereas coupled enzyme reactions in the 
plate reader had a Km= 0.75 ± 0.04 mM and a Vmax = 25 ± 0.3 µM min-1. A 2.2-2.5 times 
difference was observed between the Km and Vmax values.  
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Figure 3-8:  Michealis-Menten plots of coupled enzyme reactions in picoliter volume 
reaction device (ν) and plate reader (λ).The Km and Vmax for the reaction device were 
found to be 1.65 ± 0.17 mM and 67 ± 1.4 µM min-1 respectively. (b) The Km and Vmax for 
the coupled enzyme reactions in the plate reader were found to be 0.75 ± 0.04 mM and 25 
± 0.3 µM min-1 respectively. 
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Figure 3-9:  Lineweaver-Burk reciprocal plots for coupled enzyme reactions in plate reader 
and device. (a, blue diamond) The Km and Vmax for the plate reader were found to be 0.59 
± 0.01 mM and 23 ± 0.8 µM min-1 respectively. (b, pink square) The Km and Vmax for the 
coupled enzyme reactions in the device were found to be 0.587 ± 0.02 mM and 49 ± 1.4 
µM min-1 respectively. 
 
 
 
 
 
a. 
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One possible reason that the device and plate reader reactions have different Km 
and Vmax values could be that product inhibition takes place in the batch reactions. The 
plate reader is a closed system and the reaction of high concentrations of glucose with 
glucose oxidase produces an excess of H2O2, which can oxidize resorufin to 
nonfluorescent resazurin. Therefore it makes it seem as if less enzymes were present in 
the reaction and less product was formed at a longer time. On the other hand, the small 
reaction device with its nanometer size slits prevents build up of H2O2 and therefore 
allows for a better determination of enzyme kinetics. However, the effect of product loss 
from the reaction device should also be taken into consideration. Since resorufin is a 
small molecule, it can diffuse out of the device and may not be accounted during enzyme 
kinetics. The diffusion experiments described above show that ~40% of fluorescein 
diffuses out of a 7 min PECVD device within 2 minutes, which is the time that it takes 
for most of the enzyme reactions to reach Vmax. Fluorescein has a comparable size with 
resorufin therefore it can be assumed that ~40% of the product leaves the reaction device 
before Vmax is reached, which should increase Vmax. However, since substrate, amplex red 
and H2O2 are also transported through the pores of the device at the same time that 
resorufin is diffusing out, the amount of product that diffuses out and is not included in 
kinetics calculations should be much smaller than 40%. Nevertheless, a model that 
accounts for diffusion of all small molecules involved in the reaction is necessary in order 
to have a more realistic Vmax.   
Nevertheless, a model that accounts for diffusion of all small molecules involved 
in the reaction is necessary in order to have a more realistic Vmax. Substrate mass 
diffusion in and out of the device and better mixing can also allow for a higher Vmax in 
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the device.  Mass diffusion is a key point when considering enzyme reactions in small 
volume containers. The best situation is when diffusion of substrate and product is not the 
rate limiting process, which leads to better estimation of enzyme kinetics. The Michaelis-
Menten model, for low substrate concentrations, is directly depended on the diffusion rate 
of the substrate into the device (Table 3.1). In this diffusion-controlled system, there is a 
linear correlation between the reaction rate results and the substrate concentration [190]. 
This diffusion-limited linearization of the catalytic rate applies for low substrate 
concentrations whereas the high substrate concentrations still represent the Michaelis-
Menten model. As shown in the fluorescein diffusion data, product is leaving the device 
at a fast rate even for devices that have undergone 7 minute PECVD. Therefore, 
optimization of the width of slits is a necessary step for an unbiased evaluation of enzyme 
kinetics. Since both enzymes are too big to diffuse out of the device, optimization for the 
diffusion of glucose, amplex red and resorufin are the main factors.  Therefore, a 
deterministic model of diffusion and enzyme conversion is a necessary step.  
The enzyme microreactor described here offers a number of practical advantages that go 
beyond real time monitoring and optimization of reaction systems. It has a relatively thin 
membrane, the pores of which can be tuned to allow a wide range of exchange rates. It 
can also be designed in an array platform, which allows for fast, high-throughput 
screening of several enzymes and substrates simultaneously, drug discovery and clinical 
diagnostics. 
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Table 3-1:  Michaelis-Menten Kinetic Variables for Coupled Enzyme Reactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Reaction Device 96-well plate 
  Km 1.65 ± 0.17 mM 0.75 ± 0.04 mM 
  Vmax 67 ± 1.5 µM min-1 25 ± 0.3 µM min-1 
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3.4. Conclusion 
 
Here we described a nanoporous, picoliter reaction device, which under 
continuous-flow is used to measure enzyme kinetics in a microfluidic system. This 
platform has several significant advantages such as (1) the device is integrated with 
microfluidics to manipulate the surrounding environment and provide a fast and 
convenient monitoring of the activity of different enzymes; (2) the multi device platform 
allows for a high-throughput screening of several enzymes and substrates; (3) the 
enzymes are trapped inside the device in their native form and (4) the devices can be 
prepared with a controlled nanometer-size porosity which allows for fast mass transfer 
kinetics and removal of inhibitory byproducts. These picoliter reaction devices will have 
a key role in probing biological systems and better understanding self-organization at the 
micro scale. They could also interact with biological systems, sense abnormal conditions 
and respond with appropriately dose reagents.   
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Chapter 4  
Cell-Free Transcription/Translation in engineered 
picoliter volume containers 
 
This chapter is based on a manuscript reprinted from 2009 First Annual Ornl Biomedical 
Science & Engineering Conference: Exploring the Intersections of Interdisciplinary 
Biomedical Research, Siuti, P.; Retterer, S.T.; Chang Kyoung Choi; Fowlkes, J.D.; 
Doktycz, M.J.; , "Cell free translation in engineered picoliter volume containers," pp.1-4, 
Copyright (2010), with permision from 
 
IEEE Xplore Digital Library 
Data, images and text relevant to this study are included in this chapter. Images are 
presented in color where they were published in black and white. Under the direction of 
the co-authors, I conducted the experiments, analyzed the resulting data, and drafted the 
manuscript. The co-authors responded with editorial comments and additional text where 
needed. 
 
4.1. Introduction 
 
Synthetic biology is a relatively new discipline that can help to elucidate many of 
the mysteries of cell biology and enable us to develop new applications related to the 
fabrication of nanostructures and biomaterials, medicine, biosensing and energy 
production [5, 72, 102]. By combining genes, synthetic biologists are successfully 
inserting the equivalent of chemical factories into microorganisms that enable new forms 
of cellular control and enhance our understanding of basic cellular operations.   
Advancements in nanotechnology have created opportunities for synthetic biologists to 
match the scale of biological system components and create biologically inspired devices 
[5].  One example is cell mimics, where the cell’s small volume and controlled flux is 
mimicked in order to carry out reaction systems. These small volume devices can 
establish favorable conditions for protein production and function. They can also be used 
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to understand biological systems, study single molecule reactions and examine self 
organization at the cellular scale [5, 45, 46, 191, 192] 
Commonly, liposome vesicles are used as model systems to mimic the function of 
the cellular membrane. Since these vesicles are made of natural lipids, they are 
biocompatible with membrane proteins, which can be used to facilitate material exchange 
[5, 72, 74, 78]. Water in oil emulsions have also been used to create small reaction 
volumes [91, 102]. However, the long-term stability of liposome vesicles and water in oil 
emulsion structures can be problematic [5]. Additionally, such systems are difficult to 
integrate with synthetic control mechanisms and devices, which leads to the need for 
more robust and reliable vesicles.  
Microfabrication and nanotechnology based techniques can be used to create such 
robust reaction containers from inorganic materials. The small volume devices can be 
used for a variety of applications including: high throughput screening [135], enzyme 
kinetics [130], analysis of single cells [193] and cell-free protein synthesis [5, 132, 135, 
194]. They can be patterned in different materials, shapes and pore sizes and can be 
physically or chemically modified to control the flux of molecules of different sizes and 
charges so that they mimic some of the characteristics of a natural cell. Such a silicon 
based device is described here. It can be used for studying biochemical reactions and the 
effects of scale and compartmentalization on reaction efficiency. The cylindrical 
container is 2µm thick with 8 sets of 7 slits spaced around the perimeter. Slits are etched 
in the same processing step as the device and can range in size from 30-200 nm wide and 
10 nm deep. Devices can be created without slits as well. These small volume containers 
can be used to characterize reaction systems and material organization in a fluid 
  79 
environment. They can also be used to “self assemble” reaction systems. Further, the 
device allows for controlled transport between the local environment and the contained 
volume through the synthetic membrane. Cell-free transcription and translation reactions 
conducted in this container would be useful for producing functional proteins as needed 
for biomedical applications.  Reported here is the use of a picoliter volume containers 
(Figure 4.1) to conduct cell-free protein synthesis. Further, the optimal DNA 
concentration and the time required for maximal protein yield in the device is determined. 
4.2. Materials and Methods 
 
4.2.1. Device Fabrication 
 
Reaction containers were fabricated using semiconductor processing techniques to 
define membrane characteristics. Feature fabrication was achieved using electron beam 
and optical lithography, followed by cryogenic etching and plasma enhanced chemical 
vapor of silicon dioxide.  Each fabrication run, results in a silicon wafer with 8 
completed chips. Each chip consists of 2 channels with 15 containers per channel 
(Figure 4.2a, b). For the experiments described here, the resulting containers have a 
volume of ~19 pL and are made with either no slits or 200nm slit sizes.  
The Sylgard 184 silicone elastomer kit was used to prepare Polydimethylsiloxane 
(PDMS), which is used to seal the top of the devices. Sylgard 184 silicon base and the 
curing agent were mixed together in a Petri dish at a 10 to 1 ratio, respectively.  The 
homogeneous mixture was degassed in a desiccator for ~30 min until the air bubbles 
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Figure 4-1:  Wafer with 8 chips and sealed device. 
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Figure 4-2:  Scanning Electron Microscope (SEM) images of the device (a) Container 
with no slits (b) Container with 200 nm slit size (c) 200 nm slits. 
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were removed and was later placed in the oven at 70˚C for 60- 90 minutes. After baking, 
PDMS was cut into pieces in the shape of the chip and two holes were created on each 
end of the channel to allow for the input and output of the reaction mixture (Figure 4.2c).     
4.2.2. Cell Free Translation 
 
Escherichia coli (E. coli) T7S30 Extract System for Circular DNA reaction kit 
(Promega TB219) was used for transcription/translation experiments according to the 
manufacturer’s directions. For the template, enhanced green fluorescent protein (EGFP) 
gene was cloned into pDEST17 (Invitrogen), which allows expression of EGFP from a 
T7 promoter (Figure 4.3). The solution containing the DNA template and the cell free 
transcription/translation mix was mixed in a 1:1 ratio with 8 % glycerol and placed in the 
cell mimic using a glass tip with 2 µm orifice (World Precision Instruments, TIP2TW1). 
After the structures were loaded, the chip was covered with a 5 mm thick layer of PDMS.  
The channel was then filled with E. coli S30 cell free extract and small metabolites. The 
experiment was incubated at 37˚C. EGFP fluorescence was visualized using a Zeiss 
Axioskop 2 FS Plus epifluorescent microscope. A similar procedure was also followed 
for cell-free transcription/translation in containers containing no slits. In this case, the 
DNA template was mixed with E. coli T7S30 cell free extract and small metabolites in a 
1:4 ratio, and a final 4 % glycerol concentration. The entire reaction mixture was then 
loaded into the device using a 2 μL glass microtip (World Precision Instruments, 
TIP2TW1). Several mimics were filled with E. coli T7S30 cell free extract and were used 
as negative controls. The chip was then covered with PDMS and fluorescence was 
measured. The experiment was incubated at 37˚C. In order to compare cell-free   
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Figure 4-3:  Plasmid encoding for EGFP. The plasmid is based on the pDEST17 vector 
backbone with a T7 inducible promoter. The size of the plasmid is 5418 bp. 
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translation in the device with conventional scale reactions, cell-free translation was also 
conducted in a Costar 96 flat bottom well plate (Figure 4.4a). The concentrations and 
temperature were kept the same as in the device reactions. The final reaction volume in 
the plate well was 50 µL and fluorescence was measured every 10 minutes using a Perkin 
Elmer HTS 7000 Plus BioAssay Reader. 
4.2.3. Characterization 
 
An EGFP standard was prepared by diluting purified GFP protein to 
concentrations of 26.2, 13.1, 6.55, 3.275, 1.64, 0.82, 0.41, 0.205 and 0.103 µM EGFP. 
Each of the EGFP solutions contained 4 % glycerol concentration. These solutions were 
loaded in no pore devices and fluorescence was measured using identical settings for 
devices with no pores or with 200nm pores. EGFP concentration produced in the cell-free 
transcription/translation reactions in the no slit and 200 nm slit size mimics was measured 
against this EGFP standard.  For all the experiments, images were taken every 10 minutes 
using a dry 40x objective at an exposure time of 500 milliseconds. A 3CC syringe with a 
19 gauge needle was used to flow the reaction mix into the channel. 
4.3. Results and Discussion 
To test the ability of the microfabricated picoliter volume containers to carry out 
biochemical reaction systems, cell-free protein synthesis experiments using no slits and 
200 nm slit size devices (Figure 4.5) were carried out. Due to the low viscosity of the 
reaction mix and the small volume of the container (19 pL), we encountered several  
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Figure 4-4:  Standard curve of different EGFP concentrations in (a) cell mimic device (b) 
plate reader 
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Figure 4-5:  Cell-free transcription/translation in cell mimic devices.  (a) Container with 
200nm slit size (b) Container with no slits. 
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difficulties when loading the device. These difficulties consisted of overflowing the 
device at the time of loading, air bubble formation inside the device and quick drying of 
the sample immediately after loading. In order to overcome these difficulties, the reaction 
was mixed with different solutions that altered viscosity and evaporation time.  
Evaluated solutions included polyethylene glycol (PEG), 1% alginate, glycerol, 
dimethyl sulfoxide (DMSO), agar, dimethylformamide (DMF) and several sucrose 
concentrations.  All these solutions increased viscosity of the reaction mix making it 
easier to load the devices. Evaporation of the reaction mix after loading the device was 
also overcome. Protein production was also evaluated and it was significally decreased. 
In many cases it was completely inhibited. Alginate was the only solution of those tested 
that increased protein yield, however it was difficult to handle when loading the device as 
cross-linking of the mixture would often occur. The most useful solution, which did not 
significantly decrease cell free transcription/translation was glycerol. There was a small 
decrease in protein yield when using glycerol, but the increased viscosity made it easier 
to load the device and air bubble formation was avoided. Therefore, several glycerol 
concentrations were tested and the lowest one, which still allowed effective loading of the 
devices and avoided evaporation was determined to be 4% glycerol concentration.  
Cell-free transcription/translation experiments were successful for small volume 
containers that contained no slits and 200 nm slits (Figure 4.6). The reaction yield was 
consistent in the no slit devices and the optimal DNA concentration was determined. It 
was found that 90 ng/µL DNA concentration had the highest EGFP yield (Figure 4.8) 
followed by 75 ng/µL.  
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Figure 4-6:  Cell-free transcription/translation in no pore devices with different DNA 
concentrations. Reaction after (a) 60 minutes (b) 90 minutes (c) 120 minutes. 
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Figure 4-7:  Cell-free transcription/translation in no pore cell mimic devices. (a) Protein 
production with different template concentrations of 120, 60 and 0 ng/µL DNA (b) Time 
progression of cell-free transcription/translation of 120 ng/µL DNA template on a no 
pore cell mimic device. 
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Figure 4-8:  Cell-free protein expression in (a) plate reader and (b) no slit device. The 
graph represents the protein concentration, corresponding to the observed fluorescence 
intensity, from three protein synthesis experiments (3 individual devices on 3 separate 
chips). Error bars represent +/- one standard deviation.  
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The other concentrations tested had a similar EGFP yield of ~ 0.1 µM. When compared 
to experiments carried out at the conventional scale (50µL), a plateau was reached at 
template concentrations greater than 60 ng/µL (Fig. 4.8). Cell-free 
transcription/translation in 200nm slit size cell mimic devices was more difficult to 
achieve and typically GFP was produced throughout the entire microfluidic channel. This 
could be caused by (a) GFP leaking out of the device through the slits after it was 
produced or (b) the mRNA leaking out and translation occurring in the channel instead of 
only in the device. GFP observation in the channel was eliminated when the buffer was 
flowed through the channel using gravity. Under these conditions, GFP was detected only 
in the reaction chamber. Therefore, a better understanding of the effect of pore size and 
viscosity on cell mimic loading and protein production is necessary. 
4.4. Conclusion 
 
In this chapter we demonstrated cell free transcription/translation in the picoliter reaction 
devices with no pores or with 200 nm pore size. The reaction yield was consistent in the 
no pore devices and the optimal DNA concentration was determined. Optimal template 
concentration required for eGFP production was also determined. 
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Chapter 5  
Continuous protein production in nanoporous, picoliter 
volume containers under continuous flow conditions 
 
This chapter is based on a manuscript submited to Lab on a Chip, Siuti, P.; Retterer, S.T.; 
and Doktycz, M.J., "Continuous protein production in nanoporous, picoliter volume 
containers,"  
 
Data, images and text relevant to this study are included in this chapter. Images are 
presented in color where they were published in black and white. Under the direction of 
the co-authors, I conducted the experiments, analyzed the resulting data, and drafted the 
manuscript. The co-authors responded with editorial comments and additional text where 
needed. 
 
5.1. Introduction  
 
Protein production is fundamental to the function of biological systems and is the 
technological cornerstone for the manufacture of biological therapeutics. A growing 
amount of genetic information has highlighted the need to rapidly screen protein activity 
[195] while protein-based “biologics” are emerging as an important class of 
pharmaceuticals [196-198]. Conventionally, protein production is carried out using live 
host cells. However, protein degradation, insolubility, cytotoxicity and yield [199, 200] 
can complicate this approach.  Cell-free methods are a promising alternative and use 
isolated components of a cell’s transcription and translation machinery to express 
proteins from DNA-based instructions [56, 201].   
Cell-free methods have proven practical for preparing proteins that are difficult to 
express in vivo, including complex macromolecular assemblies and membrane 
proteins[67, 202-204].  Since other aspects of cellular metabolism are not necessarily 
required, problems associated with conflicting reactions, codon biases, protein solubility 
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and toxicity can be avoided.  Further, conditions can be customized to facilitate protein 
folding [56, 205] or gene expression [206].  Although, the cell-free nature of the reaction 
can enable greater control of reaction conditions, and potentially focus energy 
requirements towards protein production, problems associated with reaction optimization, 
reaction extent and product yield persist.  
One origin of these shortcomings is the concurrent depletion of reaction nutrients 
and the build-up of reaction byproducts that inhibit protein synthesis[207]. This can 
abbreviate the reaction period and results in low protein yields. Spirin’s introduction of 
reagent exchange to cell-free protein synthesis marked a major advance [82].  By 
continuously supplying reactants and removing byproducts through a membrane, 
maintenance of protein synthesis for up to several days was possible. Modifications to 
this approach continue to increase protein yield over that of batch reactions [55, 56, 59, 
207-209]. Typically, components that can facilitate or interfere with optimal protein 
production are added or removed from the system [60].  The development of the PURE 
system, where individual components of the transcription/translation machinery are 
expressed, purified and combined for cell free transcription/translation, marked another 
significant development [81].  Using just essential components can facilitate optimal 
protein production, provided peak conditions are identified and all essential reactions are 
accounted for.  Nevertheless, the development of the PURE system represents a 
significant step forward in the engineering of complex biochemical reactions for specific 
application.  
Continuous exchange reactions are typically carried out at fairly large scales when 
compared to the biological cell.  Further, they often lack sophisticated control over the 
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membrane properties and resultant material exchange. Significantly reducing the scale of 
cell free translation reactions can facilitate functional screening of proteins[63, 70, 131, 
134] and exploit the scaling advantages of a biological cell [5].  Small volumes enable 
efficient diffusion-based mixing. Furthermore, the increase in surface area to volume 
allows for greater control over material flux with the environment [210]. Mimicking such 
aspects of the cell may improve cell free translation. Here we demonstrate the advantages 
of a “cell mimic” device for such purposes.  A cellular scale, nanostructured membrane 
fabricated in silicon, is used to confine DNA instructions and cell free extract 
components. Microfluidics are used to deliver and remove materials via diffusion-
mediated exchange across the membrane (Figure 5.1) enabling long-term production of 
functional proteins. The nanostructured membrane facilitates selective material transport 
and can be modified to tune material exchange. Many devices can be implemented in 
parallel making the platform suitable for larger scale production of a single protein or for 
simultaneous functional analyses of multiple proteins.  
5.2. Materials and methods 
5.2.1. Device Fabrication 
 
The small volume reaction vessels were fabricated as previously described in 
Retterer et al [159]. Briefly, patterning of the reaction vessels and microfluidic network 
was achieved using a combination of electron beam and optical lithography respectively. 
Patterning was followed by cryogenic silicon etching to simultaneously create the 
nanoporous structures and fluidic network. Subsequent plasma enhanced chemical vapor 
deposition (PECVD) was performed to further reduce pore apertures. Each fluidic 
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network contains two inlets arranged in a Y-configuration and one outlet. The resulting 
silicon wafer contains eight identical chips. Each chip contains two channels, each with 
an array of 18 reaction containers (Figure 5.1). The individual reaction containers and the 
microfluidic channel are ~15 µm tall.  The containers are 40 µm in diameter, resulting in 
a volume of ~19 pL, and possess 56 nanoscale slits.  The limiting aperture of the slits is 
on the order of 10 nm as determined by ion beam milling and cross section analysis 
[211].  Polydimethylsiloxane (PDMS), prepared from a Sylgard 184 silicone elastomer 
kit (Dow Corning, Midland, MI), was used to seal the channels and the containers after 
devices were filled with the reaction components. Holes were made at the ends of the 
channel for the inputs and output of the network and fitted with tygon tubing and 
appropriate gauge needle and syringe. 
 
5.2.2. Cell Free Transcription/Translation 
 
Cell-free transcription/translation experiments were assembled in the containers 
using Escherichia coli (E. coli) S30T7 High-Yield Protein Expression System reaction kit 
(Promega TM306) with minor modifications to the manufacturer’s directions. A 
pDEST17 (Invitrogen) plasmid with a cloned enhanced green fluorescent protein (EGFP) 
gene controlled by a T7 promoter was used as DNA template. The reaction container was 
filled with a mixture containing the DNA template, T7S30 Extract and S30 Premix Plus 
in a 1:2:1 ratio, respectively. The same mixture, with nuclease-free water used in place of 
the DNA template, was used as a negative control. To fill the containers, a glass capillary 
with a 2 µm orifice (World Precision Instruments, TIP2TW1) was used.  Subsequently, 
the chip was covered with PDMS. To supply the reaction with secondary energy 
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Figure 5-1:  A nanoporous, picoliter volume cell mimic platform for continuous protein 
production. (a) SEM micrograph of a microfluidic device with an array of 18 reaction 
containers. The inset SEM micrograph shows a single reaction container. (b) Schematic 
of a nanostructured reaction container where transcription/translation reaction mix, along 
with DNA template is loaded and sealed with PDMS. (c) The microfluidic channel 
continuously delivers and removes materials from the reaction chamber to facilitate cell 
free protein synthesis. 
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source, amino acids, rNTPs, tRNAs, and salts required for translation, E. coli S30 Premix 
Plus from the kit was flowed through the fluidic network. The chip was incubated at 37˚C 
using a stage warmer.  
Images of the cell free transcription/translation reaction were collected every 5 
minutes for the duration of the experiment using a Zeiss Axioskop 2 FS Plus 
epifluorescent microscope equipped with a 200 W mercury arc lamp and a 40x objective. 
The images were collected using an exposure time of 400 ms using a Retiga firewire 
camera synchronized with a Lambda SC smart shutter (Sutter, CA) to minimize 
unwanted photobleaching of the EGFP during the experiments. Image acquisition 
software IPLab 4.0.8 (Scanalytics, Inc) was used to acquire the images. Programs to 
calculate and plot image intensity values were written using ImageJ and MATLAB 
(V7.2, MathWorks). To allow quantitative comparisons between experiments, binning, 
exposure times and camera settings were kept the same.  
For comparison, conventional scale cell-free transcription/translation experiments 
were carried out in Costar 96 well flat bottom microwell plates using a Perkin Elmer HTS 
7000 Plus BioAssay Reader. These reactions were assembled to a final volume of 50 µL 
using both the manufacturer recommended concentration and the same concentration 
ratios as used in the cell mimic containers. 
5.2.3. Quantifying Cell-Free Transcription/Translation Reactions 
 
An EGFP standard was prepared by standard methods[63] by diluting purified 
EGFP protein to concentrations ranging from 26.2 to 0.103 µM EGFP and loading them 
in the channel. Fluorescence was measured using identical settings as for the 
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experiments. GFP concentration produced in the cell-free transcription/translation 
reactions was measured against this EGFP standard.  
For quantifying new protein synthesis in the devices, cell-free 
transcription/translation reactions were assembled and carried out as described in section 
B. Reaction progress was monitored by collecting images every 5 minutes for up to 25 
hours. At selected times, the reaction containers were photobleached by opening the 
shutter for a total of 2.5 minutes. Photobleaching and the subsequent fluorescence 
recovery rate were measured at time points of 3, 6, 9, 12, 15, 18, 21 and 25 hours. The 
fluorescence recovery rate was measured against the EGFP standard.  
For halting new protein synthesis in the devices, the cell-free 
transcription/translation reactions were carried out as described above but treated with 
chloramphenicol at selected time points. For these experiments, Chloramphenicol at a 
concentration of 5 µg/mL in E. coli S30 Premix was introduced into the second inlet 
channel as the flow from the first inlet channel was stopped.  After a 1 hour treatment 
with the Chloramphenicol solution, the feed solution was switched back to the E. coli S30 
Premix Plus. Images were collected every 5 minutes for the duration of the experiment. 
5.3. Results 
5.3.1. Cell Free Transcription/Translation 
 
To test the ability of the cell mimic devices to carry out cell-free protein 
synthesis, effective experimental conditions for filling the devices and carrying out the 
reactions were first determined. Several difficulties such as overflowing, quick sample 
drying and air bubble formation were encountered while loading the device. These 
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difficulties, which were due to the small volume of the container (~19 pL) and the low 
viscosity of the reaction mix, were overcome by examining the effects of loading 
different ratios of T7S30 Extract and S30 Premix Plus. The T7S30 Extract is more 
viscous and takes longer to evaporate than S30 Premix Plus. A reaction mix consisting of 
a 2:1 ratio of T7S30 Extract to S30 Premix Plus was found to be optimal. The new 
reaction mix had an increased viscosity, which made it easier to load the device, avoid air 
bubble formation, and reduce the effects of evaporation before sealing of the device with 
PDMS.  Arrays of up to 18 devices could be prepared in this manner and only a brief 
amount of time (~20 minute) was needed to prepare the reaction mix, load the device and 
begin measurements.  
Long periods of protein synthesis were achieved by flowing S30 Premix Plus 
through the microfluidic channel surrounding cell mimic devices.  Devices were filled 
with a reaction mix consisting of a 2:1 ratio of T7S30 Extract to S30 Premix Plus 
(commercial products from Promega) along with DNA encoding EGFP. A 2:1 ratio of 
extract to premix was found to provide an optimal viscosity for efficiently filling devices.   
The S30 Premix Plus contains an ATP-regeneration system, amino acids, tRNAs, rNTPs 
and appropriate salts needed for protein production. Diffusion of these materials into the 
cell mimic devices replenishes essential metabolites needed for cell free protein 
synthesis.  Flow rates of 1, 5, 10 and 20 µL/hr were examined and 5 µL/hr was found to 
be optimal.  Slower flow rates were difficult to maintain for long periods using the 
syringe pump-based pumping system while higher flow rates needlessly consumed 
materials. 
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Figure 5-2:  Continuous protein production in cell mimic devices.  Protein synthesis was 
achieved by flowing S30 Premix Plus at a flow rate of 5 µL/hr through the microfluidic 
channel surrounding cell mimic devices that were loaded with DNA and other reaction 
components.  Representative fluorescent micrographs of the cell mimic devices taken a 
different time points are shown. The graph represents the average intensity recorded from 
3 individual reaction containers during 3 separate cell-free translation experiments.  Error 
bars representing +/- one standard deviation are shown at 5 hour intervals for clarity. 
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The EGFP protein concentration in a cell mimic device, as determined from 
fluorescent imaging and comparison to standards, was found to increase for the first 1-2 
hours and then reached a plateau that was maintained for the next 24 hours. Additional 
engineering of an appropriate fluid delivery system will be needed to consistently carry 
reactions well beyond 24 hours. The maximum concentration observed in the cell mimic 
device was 0.35 µM. For comparison, standard 50 µL batch reactions were carried out in 
microwell plates using the similar reaction conditions.  Standard 1:1 ratios of T7S30 
Extract to S30 Premix Plus as well as the 2:1 ratio used in the cell mimic 
devices were examined. The maximum observed GFP concentrations were similar and 
found to peak at 3.5-4 µM after 3 hours. 
5.3.2. Quantifying Protein Synthesis and Release 
 
In order to determine if new protein is continuously synthesized throughout the 
experiment, the cell free translation reactions were photobleached at selected time points. 
A recovery in EGFP fluorescence would indicate new protein synthesis (Figure 5.3).    In 
each case, an individual cell mimic device was exposed to 2.5 minutes of excitation light. 
Fluorescence recovery was observed and reached a maximal value within 1-2 hours.  This 
value was maintained throughout the remainder of the experiment. When bleaching 
occurred at later time points, a new steady state was observed at a lower signal level.  The 
fluorescence recovery rates are summarized in Figure 5.4. A steady decrease in the 
recovery rate, which is related to the rate of new synthesis, is observed as reaction time 
progresses.  Some decrease in this rate may be due to damage to proteins besides EGFP  
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Figure 5-3:  Protein synthesis recovery after photobleaching. The protein synthesis 
reaction in the cell mimic device was photobleached for 2.5 minutes after (a) 3 and 6 
hours. (b) 3 and 9 hours. (c) 9 and 18 hours. (d) 15 and 21 hours. The reaction recovered 
after each photobleach and continued to synthesize EGFP, as indicated by the fluorescent 
recovery, beyond 24 hours. Each graph represents the protein concentration, 
corresponding to the observed fluorescence intensity, from three protein synthesis 
recovery after photobleaching experiments (3 individual devices on 3 separate chips). 
Error bars represent +/- one standard deviation and are shown at 4 hour intervals for 
clarity. 
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as protein synthesis recovery was not observed with bleach pulses that exceeded 3 
minutes. 
To assess the rate at which EGFP exits the cell mimic device, protein synthesis 
was blocked by adding chloramphenicol at selected time points. Chloramphenicol 
inhibits protein biosynthesis by binding to the peptidyl-transferase center of the ribosome 
and preventing peptide bond formation [212, 213]. Chloramphenicol was introduced by 
switching to an alternate flow stream, upstream of the fluidic chamber that contains the 
array of cell mimic devices.  In each case 5 µg/mL chloramphenicol was combined with 
S30 Premix Plus and flowed for 60 minutes.  After which, the flow stream was switched 
back to S30 Premix Plus.  Fluorescence images were recorded at five minute intervals 
throughout the experiment (Figure 5.5). In each case, fluorescence decayed completely 
within 1 hour and new protein synthesis was not observed, even after removal of 
chloramphenicol. The rate of protein diffusion out of the device can be related to the 
fluorescence decay and found to be 5.25 nM/min at either time point. Collectively, the 
results of the photobleaching and chloramphenicol treatments indicate that protein 
synthesis is continuous throughout the reaction period and is balanced by diffusion of 
product from the cell mimic device.  For the steady-state conditions observed it can be 
assumed that the diffusion of EGFP from the device, at a rate of 5.25nM/min, provides a 
conservative estimate of EGFP production. 
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Figure 5-4:  Fluorescence recovery rates. A steady decrease in the production rate, the 
rate of new protein synthesis as measured by the increase in fluorescence, is observed as 
reaction time progresses. Recovery rates were calculated by measuring the slope of 
photobleaching recovery curves for the first five minutes following the photobleach 
pulse.  Error bars represent +/- one standard deviation 
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Figure 5-5:  Blockage of protein synthesis by antibiotic treatment,  .  Adding 
chloramphenicol at selected time points blocked the protein synthesis reaction allowing 
estimation of protein loss from the device. Chloramphenicol was introduced in the 
reaction after 3 and 15 hours by switching to an alternate flow stream, upstream of the 
fluidic chamber that contains the array of cell mimic devices. The graph represents the 
average normalized intensity recorded from 3 individual reaction containers during 3 
separate experiments.  Error bars representing +/- one standard deviation are shown at 4 
hour intervals for clarity. 
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5.4. Discussion 
 
Understanding the myriad functions carried out by proteins represents an 
immense task. Addressing this challenge requires the ability to produce and characterize 
proteins, and, to this end, microscale protein synthesis is emerging as a valuable tool. 
By reducing the scale of synthesis, numerous proteins or protein variants can be produced 
economically and in parallel thereby facilitating functional analyses and comparisons. 
By preparing proteins in situ, such as in an array format, screening is greatly facilitated, 
as are applied uses such as integration with electronic or optical sensing methods. Prior 
demonstrations have employed small volume wells [63, 70, 131, 132, 134], or surface 
tethered DNA templates [214-217] to self-assemble protein arrays through localized 
transcription and translation. Microfluidics technology is especially well suited for small-
scale synthesis [150] and can facilitate precise mixing of extremely small volumes and 
on-line detection techniques. Microdroplet-based reaction systems have been described 
and typically involve an emulsion generator to define the reaction volume [95, 218, 219]. 
These prior approaches are essentially batch reaction systems and cannot be fed 
metabolites or have toxic products removed. The implementation of continuous exchange 
systems at a reduced scale are beginning to emerge [133, 220], but these systems are 
carried out at relatively large volumes (microliter scale) and lack the ability to effectively 
exploit the fluid manipulation abilities or functional integration afforded by microfluidics 
technologies. 
The cell mimic device described here enables cell free transcription and 
translation in a discreet volume while enabling reagent exchange.  Continuous protein 
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production is observed beyond 24 hours and is enabled by the efficient diffusion-based 
mixing and the feeding/removal of metabolites and harmful byproducts. The ability to 
optically monitor the reaction and to chemically manipulate it allows for estimation of 
protein yield and related synthesis rate and material flux (Table 5.1).   Protein synthesis 
after photobleaching measurements, as measured by fluorescence recovery, indicate that 
EGFP synthesis rates in the device can range from 12.2 nM/min to 3.3 nM/min, which 
correlates to ~2,300 molec/s to ~600 molec/s (Figure 5.4). These values are conservative 
estimates, as diffusive loss occurs as protein is produced.  The peak synthesis rate occurs 
upon initiation of the reaction and steadily decreases throughout, as indicated by 
photobleaching experiments. The decrease in protein synthesis rate may result from 
accumulation of photo-induced damage to key proteins, or to the loss of essential 
reagents from the device.  Large molecules and complexes, such as the DNA template 
and ribosomes, are expected to be significantly larger than the limiting aperture of the 
nanoporous membrane. However, essential translation proteins and the mRNA can be 
smaller and may escape the device over the long time course of the experiment. Such 
concerns have been noted as cause for decreased protein yield in conventional scale 
systems [60, 221, 222].  
The membrane was designed to allow for slow release of the protein product.  The 
rate of this release can be estimated from the chemically induced stopping of the reaction 
afforded by introduction of chloramphenicol.  Upon cessation of the reaction, at either 3 
or 15 hours after initiation, the loss of fluorescence from the device occurs at a rate of 
5.25 nM/min, which correlates to ~1000 molecules/sec. This loss can be attributed to 
diffusion of EGFP out of the cell mimic device.   
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  The similarity in the rates at 3 and 15 hours indicates that the pores remain open 
and that flux through the device remains fairly constant throughout the course of the 
experiment. When compared to the measured protein synthesis rates, product loss rate 
from the device appears to limit protein production.  With this assumption, and that loss 
rate is constant throughout the experiment, the total amount of protein synthesized and 
released from a single 19 pl vessel is 0.15 fmoles. Comparison with the conventional 
scale batch reaction (Table 5.1) indicates that the amount produced is on the order of ~2.2 
fold greater on a per volume basis.  
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Table 5-1:  Summary of protein synthesis rates and yields for batch reactions and cell 
mimic devices. 
Format Reaction 
Scale 
Peak Synthesis Rate / 
Steady-State Synthesis 
Rate (nM/min) 
Equilibrium 
Concentration 
(µM) 
Total 
Yield 
Yield 
(pg)/pL of 
reaction 
volume 
Batch    50 µL              32 / NA        3.66 ± 0.40 18.3 
nmoles 
0.108 
Cell 
Mimic 
   19 pL              12* / 5.25**        0.35 ± 0.03 0.15 
fmoles 
0.234 
 
* Peak synthesis rate calculated from the initial slope of protein synthesis curves (Fig. 2) 
** Calculated based on percent of EGFP concentration decrease observed in cell mimic 
devices following chloramphenicol treatment.  Under steady-state conditions, this loss 
rate corresponds to the steady-state EGFP production rate.  
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The quantitative evaluation of the CFT reactions provides insight into potential 
approaches to further optimize protein yield.  Apparently, protein synthesis can occur at 
rates several fold higher than that observed under steady state conditions within the cell 
mimic platform. In comparison with the batch scale reactions, the peak synthesis rate can 
be 2.7 fold higher than that observed in the cell mimic device.  Low protein flux and 
retention of reaction products within the device may limit protein production as has been 
observed with larger scale systems [223]. Potentially, increasing the diffusive loss rate, 
by increasing device permeability while retaining the ability to contain essential 
translation machinery may improve yield.  In the current platform, this can be 
accomplished simply by changing the number of pores or the thickness of the membrane.  
Another source for optimization is addressing the reduction in synthesis rate 
observed over the course of bleaching experiments. While some of this decrease in 
production rate may be attributed to photodamage of essential proteins, decreases may 
also result from diffusive loss of essential translation components. Depending on the 
intended protein target, tuning the size or chemical characteristics of the nanopore may 
help to retain essential translation components while facilitating product escape. 
Alternatively, co-synthesis of these translation components may prolong translation. 
Biochemical optimizations that improve translational yield can also be considered for 
enhancing protein production [224, 225]. Additionally, the microfluidic platform offers 
opportunity for even greater efficiency in protein synthesis. Metabolite conservation may 
be realized by careful metering of the feed metabolites and by potentially recycling this 
solution. 
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Beyond facile monitoring and optimization of reaction systems, the cell mimic platform 
offers a number of practical advantages. The relatively thin but robust nanoporous 
membrane that encapsulates the reaction volume can be tuned to facilitate a wide range of 
exchange rates and reaction volumes.  Further, the ability to monolithically fabricate the 
structure and accompanying microfluidics greatly simplifies membrane integration and 
can enable creation of large-scale arrays. Such large-scale arrays can serve proteomic 
applications. Screening of protein activity can be conducted without the complications of 
using surface tethered reagents. Additionally, the platform can potentially meet the needs 
of larger scale protein production as required for biologic dosing.  Based on the current 
synthesis yields, large-scale arrays can potentially produce the microgram quantities of 
biologics needed for a typical dose, while still being realized in a miniaturized platform. 
Additional functionalities, such as control elements, collection and purification systems, 
and quality assessment measures can be integrated into a common device and potentially 
meet future needs in personalized medicine. Moreover, the extended reaction periods 
afforded by the continuous flow system can make possible the understanding of 
biochemical networks, such as transcriptional regulation or metabolic pathways, in a cell 
free context [81, 224-226] This nano-enabled approach to synthetic biology can facilitate 
a bottom up understanding of complex systems [5, 227]. 
5.5. Conclusions 
 
Protein synthesis in a cell mimic device has been demonstrated.  The picoliter volume of 
the reaction allows for efficient mixing of reagents while the nanoporous container 
enables predictable flux of reactants and products. The device is easily integrated with 
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microfluidics, to reduce and manipulate the surrounding environment, and optical 
systems to monitor the progress of the reaction. Continuous protein production, for 
beyond 24 hours, and increased yield, on a per volume basis, over that of a conventional 
scale batch reaction has been demonstrated. The ability to engineer the volume, flux and 
environment of the device can facilitate its optimization for a variety of purposes. 
Production of proteins, based on programmable DNA based instructions, can greatly 
facilitate the high-throughput screening of protein function and the development and use 
of therapeutic proteins. 
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Chapter 6  
Conclusions and future directions 
 
6.1. Summary 
 
The work presented here, represents a comprehensive development and 
investigation of a cell mimic based picoliter volume device that is able to mimic 
functional aspects of a biological cell, and function as a universal platform to study 
biochemical reactions within a cellular scale system. The nanoporous, cellular-scale 
devices have been created and modified using multi-scale fabrication techniques such as 
electron beam and contact lithography, cryogenic etching and plasma enhanced chemical 
vapor deposition. Size modification of the device pores allows for the confinement of 
larger species that represent information or functionality within a reaction system such as 
DNA, enzymes, proteins and cell free extract components while allowing smaller 
materials to freely pass through the porous membrane. The nanostructured device has 
been modified to tune material exchange and we have demonstrated functional size 
exclusion, fluorescence recovery after photobleaching, molecular containment, protein 
diffusion and a Lumped Capacitance Model for predicting transient changes in 
concentration within a nanoporous reaction vessel under moderate external flow. 
In addition, the reaction device has been used under continuous-flow to conduct single 
and coupled enzyme reactions and measure enzyme kinetics. It is integrated with 
microfluidics, to reduce and manipulate the surrounding environment, and optical 
systems to monitor the progress of the reaction. Protein synthesis in the nanoporous 
device has also been demonstrated. Continuous protein production, for beyond 24 hours, 
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and increased yield, on a per volume basis, over that of a conventional scale batch 
reaction has been achieved. Many devices have been implemented in parallel, making the 
platform suitable for larger scale production of a single protein or for simultaneous 
functional analyses of multiple proteins. 
6.2. Future Directions 
 
Although we have demonstrated success with designing, optimizing and applying 
the nanoporous picoliter volume reaction devices for different biochemical reactions, 
there will always be a need to improve upon the existing platform. A better control of the 
pore structures and their selectivity is very important in optimization of the reaction 
devices. Changing the number of pores can have a direct effect on diffusion and transport 
of materials through the membrane of the device. The size of the pores can add the 
physical restriction that is necessary to contain certain size species inside of the device 
based on the type of application that is being used. However, chemical selectivity, which 
is achieved by functionalizing the surface of the pores through immobilizing different 
reactive molecules, could give the device more cell-like characteristics and provide a 
combined physical and chemical selectivity. The volume of the reaction device can also 
be optimized to mimic the size of certain cell types or compartments. This can be 
important in determining the effect of volume and crowding on biochemical reactions.  
The ability to engineer the volume, flux and environment of the device can facilitate its 
optimization for a variety of purposes. 
The reaction devices may prove useful in fundamental studies of protein-based 
complex reaction systems and can enable the development of responsive sensors and 
  115 
therapeutic platforms that rely upon the on-demand conversion or production of 
biological materials. They could also interact with biological systems, sense abnormal 
conditions and respond with appropriately dosed reagents. 
The cell mimic devices could have a key role in probing biological systems and 
better understanding self-organization at the micro scale. Production of proteins, based on 
programmable DNA based instructions, can greatly facilitate the high-throughput 
screening of protein function and the development and use of therapeutic proteins. 
Another application for the reaction devices is to study cell-cell signaling. In a 
microfluidic coculture approach, substances released from cells or cell free 
transcription/translation confined in an up-stream reaction device can generate a response 
gradient in the down-stream devices.  Cell-cell signaling studies can be used to 
coordinate biofilm formation at a single or multiple population at a desired cell density or 
for pattern formation in a mixed population. These studies can give us a better 
understanding of quorum sensing and biofilm formation. Most known bacteria live in 
complex surface-bound interactive communities called biofilms [228]. Biofilms 
consisting of interactive communities are common, however their mode of interaction 
and development are poorly understood. The picoliter volume reaction devices 
implemented into a microfluidic chip can serve as platforms to manipulate cell 
populations and would enable controlled studies of microbial ecosystem dynamics and 
microscale environmental manipulations. We have engineered cellular circuits, which can 
be used for unidirectional and bidirectional cell-cell communication network that can 
coordinate gene expression. The signaling network has been constructed in E. coli from 
components of the LasI/LasR quorum sensing systems found in Pseudomonas aeruginosa 
  116 
[229, 230]. The network consists of a sender and receiver plasmid. The sender plasmid 
has a LasI gene (sender gene) controlled by a native promoter whereas the receiver 
plasmid has a LasR gene (receiver gene) also controlled by a native promoter and a GFP 
gene, which is controlled by a Las promoter. The signaling network works as follows: 
The sender plasmid is placed in the upstream reaction device and it undergoes cell free 
transcription/translation. The receiver plasmid is used to transform E.coli cells which are 
then placed in the downstream reaction device. The LasI protein, which is synthesized 
from the sender plasmid, uses S-adenosylmethionine (SAM) and 3-oxododecanoyl 
coenzyme A to form 3-oxododecanoyl homoserine lactone (3OC12HSL). The newly 
formed 3OC12HSL then travels downstream of the microfluidic channel. It is small 
enough to pass through the pores of the downstream reaction device that contains the 
cells that have been transformed with the receiver plasmid. After it passes through the 
membrane of the receiver cells, it forms a dimer with the LasR protein that has been 
synthesized from the receiver plasmid. The newly formed dimer (LasR-3OC12HSL) then 
activates the Las promoter and GFP is allowed to be synthesized (Figure 6.1). Initial plate 
reader experiments have been performed to determine the amount of 3OC12HSL that is 
required to activate GFP production in cells that have been transformed with the receiver 
plasmid (Figure 6.2). Other experiments that have already been performed consist of 
placing the receiver cells inside of a downstream reaction device and filling the channel 
with different concentrations of 3OC12HSL. The receiver cells started producing GFP 
after a few hours (Figure 6.3) with higher concentrations of 3OC12HSL activating the 
receiver cells quicker than lower concentrations. Spatial and temporal behavior of this 
communication network can be characterized using the present microfluidic device. 
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Figure 6-1:  Sender-Receiver system in reaction devices.  The sender plasmid containing 
LasI gene is located in the upstream reaction device. The LasI protein catalyzes synthesis 
of 3OC12HSL, which diffuses into the cells containing the receiver plasmid and forms a 
dimmer with LasR. The newly formed dimmer activates the Las promoter and allows for 
production of GFP. 
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Figure 6-2:  Receiver cell activation in a plate reader. Different concentrations of 
3OC12HSL ranging from 0.1 µM to 100 µM have been used to determine the minimum 
amount of 3OC12HSL necessary to activate GFP production in receiver cells. Each point 
represents the normalized concentration, corresponding to the observed fluorescence 
intensity, from three experiments. Error bars represent +/- one standard deviation. 
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Figure 6-3:  Activating receiver cells caged inside of a reaction device. LB media with 
different concentrations of 3OC12HSL has been flown through the microfluidic channel. 
3OC12HSL has diffused through the pores of the device and through the cell membrane 
and activated GFP production from the receiver plasmid. Each image represents a 
different reaction device. 
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